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1. Synthetic procedures 
General Procedure A: Oxalyl chloride mediated acid chloride formation and peptide 
formation 
To a stirred solution of acid (1 eq.) and DMF (0.1 mL) in DCM (2 mL/mmol) at 0 °C was added oxalyl 
chloride (1.1 eq) dropwise. The reaction mixture was allowed to return to rt and stirred for 2 h. The 
excess solvent and oxalyl chloride were removed in vacuo. A solution of amine (0.8 eq.) and Et3N (1.5 eq.) 
in DCM (2 mL/mmol) was added dropwise to the 2-azido-2-methylpropanoyl chloride residue at 0 °C and 
the reaction stirred for a further 16 h at rt. The solvent was removed in vacuo and the residue taken up in 
EtOAc (2 mL/mmol) and washed with 5% aq. KHSO4 (2 ml/mmol) and sat. aq. NaHCO3 (2 mL/mmol). The 
organic layer was dried (MgSO4), and the solvent evaporated to give the crude product. 
General Procedure B: Pd/C catalysed hydrogenation 
To a stirred solution of compound (1 eq.) in MeOH (1 mL/mmol) was added Pd/C (~0.1 mg/mg) as a slurry 
in MeOH/DCM. The reaction was stirred under an atmosphere of H2 until judged complete by TLC. The 
reaction mixture was then filtered through Celite® and the solvent evaporated to give the crude amine. 
General Procedure C: TFFH mediated acid fluoride formation and peptide formation 
To a stirred solution of Cbz-αMv-OH (2 eq.) and pyridine (2 eq.) in DCM (4 mL/mmol) was added TFFH 
(3 eq.) and the reaction left to stir for 4 h. The reaction mixture was washed with ice water (4 × 
2 mL/mmol), dried (MgSO4) and the solvent evaporated to give Cbz-αMv-F. To a stirred solution of amine 
(1 eq.) and DIPEA (1 eq.) in DCM (8 mL/mmol) at 0 °C was added Cbz-αMv-F in DCM (1 mL/mmol) 
dropwise. The reaction was stirred for 5 d at rt. Once complete the solvent was removed in vacuo and the 
residue taken up in EtOAc (2 mL/mmol), washed with 5% aq. KHSO4 (2 mL/mmol), sat. aq. NaHCO3 
(2 mL/mmol) and brine (1 mL/mmol), dried (MgSO4) and the solvent evaporated to give the crude product. 
General Procedure D: TFA deprotection of tert-butyl esters 
To a stirred solution of ester (1 eq.) in DCM (3 mL/mmol) at 0 °C was added TFA (30 eq.) dropwise. 
Reaction was stirred until judged complete by TLC whereupon all solvent was removed in vacuo to give the 
crude product. 
General Procedure E: ICBF mediated peptide formation 
To a stirred solution of acid (1 eq.) and NMM (1.05 eq.) in THF (3 mL/mmol) at −15 °C was added 
iBuCOCl (1 eq.) dropwise and the reaction stirred for 15 min. A suspension of amine (2 eq.) and NMM 





was removed in vacuo and the residue taken up in EtOAc (15 mL/mmol) and washed with 5% aq. KHSO4 
(15 mL/mmol), sat. aq. NaHCO3 (15 mL/mmol) and brine (15 mL/mmol). The organic phase was dried 
(MgSO4) and the solvent evaporated to give the crude product. 
General Procedure F: Peptide coupling through azlactone formation 
To a stirred solution of acid (1 eq.) and EDC.HCl (1.5 eq.) in DCM (5 mL/mmol) was added DIPEA 
(1.5 eq.) and the reaction stirred for 4 h. Reaction solvent was removed in vacuo and the residue taken up 
in EtOAc (5 mL/mmol. The organic layer was washed with 5% aq. KHSO4 (2 × 3 mL/mmol) and brine 
(3 mL/mmol), dried (MgSO4) and the solvent removed in vacuo to give the azlactone. A solution of 
azlactone in MeCN (5 mL/mmol) was added to amine (1 eq.) and the reaction stirred at reflux for at least 
5 d. The reaction mixture was then allowed to cool, the solvent removed in vacuo and the residue taken up 
in EtOAc (10 mL/mmol). The organic layer was washed with 5% aq. KHSO4 (10 mL/mmol), sat. aq. 
NaHCO3 (10 mL/mmol) and brine (5 mL/mmol), dried (MgSO4) and the solvent evaporated to give the 
crude product. 
Cbz-L/D-αMv-OH – S1 
To a stirred solution of H-L/D-αMv-OH (1.00 g, 7.63 mmol) in acetone (17.5 mL) and 2 M 
aq. NaOH (17.5 mL) at 0 °C was added benzyl chloroformate (0.65 mL, 4.58 mmol) in 
acetone (2 mL) dropwise over 30 min. The reaction was stirred for 6 h before benzyl 
chloroformate was added again in the same manner. The pH was adjusted to 13 with 2 M 
aq. NaOH and left to stir overnight. The acetone was removed in vacuo and the aqueous diluted with 2 M 
aq. NaOH (10 mL). This was washed with Et2O (3 × 20 mL), and then acidified to pH 2 with conc. HCl. 
The aqueous was then extracted with EtOAc (3 × 30 mL), and the organic washed with brine (30 mL), 
dried (MgSO4) and evaporated to give S1 as a thick oil which crystallises over time (1.24 g, 4.67 mmol, 
61%). δH (500 MHz, CDCl3) 7.31-7.21 (5H, m, ArH), 5.29 (1H, s, br, NH), 4.14 (1H, d, J = 7.2, PhCH2), 4.11 
(1H, d, J = 7.2, PhCH2), 2.30-2.14 (1H, m, CH(CH3)2), 1.50 (3H, s, NHC(CH3)), 0.92 (3H, d, J = 6.9, 
CH(CH3)2), 0.89 (3H, d, J = 6.9, CH(CH3)2); δC (125 MHz, CDCl3) 178.4 (CO2H), 155.6 (CONH), 136.2, 
128.6, 128.2, 128.1 (Ar), 66.9 (NHC(CH3)), 63.0 (PhCH2), 34.7 (CH(CH3)2), 18.8 (NHC(CH3)), 17.3 
(CH(CH3)2), 17.1 (CH(CH3)2); (L) [α]D20 = +16.0 (c 0.33, CH3OH), (D) [α]D20 = −16.2 (c 1.00; CH3OH) 








Cbz-L/D-αMv-NHMe – S2 
 According to the procedure of Toniolo:2 To a stirred solution of S1 (1.23 g, 4.64 mmol), 
HOBt (1.03 g, 6.96 mmol) and DIPEA (1.20 mL, 6.95 mmol) in DCM (15 mL) was added 
EDC.HCl (133 g, 6.96 mmol) and left to stir for 1 h. MeNH2.HCl (938 mg, 13.9 mmol) 
was added with DIPEA (3.25 mL, 13.9 mmol) and the reaction was stirred for 16 h. 
When complete the reaction mixture was taken up in EtOAc (60 mL), and washed with 
5% aq. KHSO4 (40 mL), sat. aq. NaHCO3 (40 mL) and brine (20 mL). The organic layer was dried (MgSO4) 
and the solvent evaporated to give the crude product. This was purified by flash column chromatography 
(1:1 PE:EtOAc increasing to 1:4) to give pure S2 as a clear oil (993 mg, 3.57 mmol, 77%). δH (500 MHz, 
CDCl3) 7.23-7.14 (5H, m, ArH), 6.82 (1H, s, br, NH), 5.69 (1H, s, NH),  4.97 (1H, d, J = 12.3, PhCH2), 4.91 
(1H, d, J = 12.3, PhCH2), 2.62 (3H, s, NHCH3), 2.26-2.08 (1H, m, CH(CH3)2), 1.37 (3H, s, NHC(CH3)), 0.79 
(3H, d, J = 6.9, CH(CH3)2), 0.77 (3H, d, J = 6.9, CH(CH3)2); δC (125 MHz, CDCl3) 174.3 (CONHCH3), 
155.5 (CONHCH2), 136.2, 128.5, 128.1, 128.0 (Ar), 66.6 (NHC(CH3)), 63.2 (PhCH2), 34.5 (CH(CH3)2), 26.5 
(NHCH3), 18.0 (NHC(CH3)), 17.1 (CH(CH3)2), 17.0 (CH(CH3)2); (L) [α]D20 = +6.4 (c 0.50; CH3OH), (D) 
[α]D20 = −6.4 (c 1.00; CH3OH) (Lit = ± 0.6, c 0.50). Data are in accordance with literature values. 
H-L/D-αMv-NHMe – S3 
From S2 (1.18 g, 3.96 mmol) according to General Procedure B. S3 obtained as white 
powder (553 mg, 3.84 mmol, 97%). Rf 0.24 (EtOAc); m.p. >235 °C (decomp); 
δH (500 MHz, CD3OD), 4.85  (2H, s, br, NH2), 2.74 (3H, s, NHCH3), 2.03 (1H, sep, J = 6.9, 
CH(CH3)2), 1.29 (3H, s, NHC(CH3)), 0.90 (3H, d, J = 6.9, CH(CH3)2), 0.81 (3H, d, J = 6.9, 
CH(CH3)2); δC (125 MHz, CD3OD) 180.6 (CONHCH3), 61.4 (NHC(CH3)), 36.4 
(CH(CH3)2), 26.3 (NHCH3), 24.8 (NHC(CH3)), 17.7 (CH(CH3)2), 16.4 (CH(CH3)2); 
νmax/cm-1 3264m.br (N-H), 2971m (C-H), 1661s (C=O), 1554m (C-N), 1515m (C-N); (L) [α]D20 = −24.0 
(c 1.04, CH3OH), (D) [α]D20 = +24.0 (c 1.07, CH3OH). 
Cbz-L/D-αMv2-NHMe – S4 
 From S1 (1.86 g, 7.68 mmol), TFFH (3.04 g, 11.5 mmol), pyridine (0.56 mL, 
7.68 mmol), S3 (553 mg, 3.84 mmol) and DIPEA (0.67 mL, 3.84 mmol) according 
to General Procedure C. Crude S4 was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure product 
(412 mg, 1.05 mmol, 27%). Rf 0.20 (1:1 PE:EtOAc); m.p. 105-108 °C; 
δH (500 MHz, CDCl3) 7.36-7.30 (5H, m, ArH), 7.24 (1H, s, br, CONH), 6.22 (1H, 





NHCH3), 1.97-1.87 (2H, m, CH(CH3)2), 1.53 (3H, s, NHC(CH3)), 1.43 (3H, s, NHC(CH3)), 0.96 (3H, d, J = 
6.9, CH(CH3)2), 0.93 (3H, d, J = 6.9, CH(CH3)2), 0.82 (3H, d, J = 6.9, CH(CH3)2), 0.66 (3H, d, J = 6.9, 
CH(CH3)2); δC (125 MHz, CDCl3) 173.9 (CONH), 171.6 (CONH), 156.2 (CO2Bn), 135.7, 128.7, 128.7, 128.6 
(Ar), 67.5 (PhCH2), 63.8 (NHCCO), 63.0 (NHCCO), 35.9 (CH(CH3)2), 35.8 (CH(CH3)2), 26.4 (NHCH3), 19.6 
(NHC(CH3)), 17.8 (NHC(CH3)), 17.3 (CH(CH3)2), 17.2 (CH(CH3)2), 17.1 (CH(CH3)2), 16.6 (CH(CH3)2); 
νmax/cm-1 3280m.br (N-H), 2965m (C-H), 1711s (C=O), 1668s (C=O), 1531m (C-N), 1497m (C-N); m/z 
(ESI+) 392.60 ([M+H]+, 100%), 414.58 ([M+Na]+, 70%), HRMS (ESI+) found [M+Na]+ 414.2361 [C21H-
33N3O4Na]+ requires 414.2369; (L) [α]D20 = +35.6 (c 0.91, CH3OH), (D) [α]D20 = −35.5 (c 1.00; CH3OH).  
H-L/D-αMv2-NHMe – S5 
 From S4 (348 mg, 0.93 mmol) according to General Procedure B. S5 was 
obtained as a clear oil (319 mg, quant.). Rf 0.43 (19:1 DCM:MeOH); δH (500 MHz, 
CD3OD) 2.76 (3H, s, J = 4.5, NHCH3), 2.30 (1H, sep, J = 6.9, CH(CH3)2), 2.22 (1H, 
sep, J = 6.9, CH(CH3)2), 1.57 (3H, s, NHC(CH3)), 1.55 (3H, s, NHC(CH3)), 1.08 (3H, 
d, J = 6.9, CH(CH3)2), 1.04 (3H, d, J = 6.9, CH(CH3)2), 1.00 (3H, d, J = 6.9, CH(CH-
3)2), 0.92 (3H, d, J = 6.9, CH(CH3)2); δC (125 MHz, CDCl3) 173.7 (CONH), 169.1 
(CONH), 64.6 (NHCCO), 64.1 (NHCCO), 35.1 (CH(CH3)2), 34.7 (CH(CH3)2), 30.1 (NHCH3), 26.7 
(NHC(CH3)), 18.6 (NHC(CH3)), 17.6 (CH(CH3)2), 17.5 (CH(CH3)2), 17.0 (CH(CH3)2), 16.9 (CH(CH3)2);	
νmax/cm-1 3362m.br (N-H), 1658s (C=O), 1494m (C-N); (L) [α]D20 = +18.4 (c 1.00; CH3OH), (D) [α]D20 = 
−18.4 (c 1.01, CH3OH). 
2-Azido-2-methylpropanoic acid – S6 
To a stirred solution of 2-bromo-2-methylpropanoic acid (15.0 g, 89.9 mmol) in DMF (80 mL) 
was added NaN3 (8.80 g, 135 mmol). The reaction was stirred for 72 h, and then diluted with 
water (30 mL) and acidified to pH 2 with 1 M aq. HCl (40 mL). This was extracted with TBME (2 × 75 mL) 
and the organic layer washed with 1 M aq. HCl (4 × 20 mL). The organic phase was dried (MgSO4) and 
concentrated in vacuo to give S6 as a yellow oil (9.90 g, 76.6 mmol, 85%).  δH (500 MHz, CDCl3) 11.54 (1H, 
s, br, CO2H), 1.52 (6H, s, C(CH3)2); δC (125 MHz, CDCl3) 179.6 (CO2H), 63.0 (C(CH3)2), 24.4 (C(CH3)2). 









From S6 (150 mg, 1.17 mmol), oxalyl chloride (0.10 mL, 1.28 mmol), S5 
(150 mg, 0.58 mmol) and Et3N (0.16 mL, 1.17 mmol) according to General 
Procedure A. Crude S7 was purified by flash column chromatography (5:1 
PE:EtOAc, increasing EtOAc) to the pure product as white crystals (123 mg, 
0.33 mmol, 58%). Rf 0.30 (5:1 PE:EtOAc); m.p. 74-76 °C; δH (500 MHz, 
CDCl3) 7.12 (1H, s, br, NHCH3), 6.93 (1H, s, CONH), 6.16 (1H, s, CONH), 
2.74 (3H, d, J = 4.7, NHCH3), 2.07 (1H, sep, J = 7.0, CH(CH3)2), 2.04 (1H, sep, J = 7.0, CH(CH3)2), 1.51 
(3H, s, NHC(CH3)), 1.50 (3H, s, N3C(CH3)2), 1.49 (3H, s, N3C(CH3)2), 1.34 (3H, s, NHC(CH3)), 0.94 (3H, 
d, J = 7.0, CH(CH3)2), 0.90 (3H, d, J = 7.0, CH(CH3)2), 0.84 (3H, d, J = 7.0, CH(CH3)2), 0.77 (3H, d, J = 7.0, 
CH(CH3)2); δC (125 MHz, CDCl3) 173.7 (CONH), 173.1 (CONH), 171.1 (CONH), 64.5 (N3C), 63.8 
(NHCCO), 63.3 (NHCCO), 35.6 (CH(CH3)2), 35.3 (CH(CH3)2), 26.3 (NHCH3), 24.3 (NHC(CH3)) 17.3 
(CH(CH3)2), 17.1 (CH(CH3)2); νmax/cm-1 3337m.br (N-H), 2968m (C-H), 2113s (N3), 1683m (C=O), 1648s 
(C=O), 1494s (C-N) 1457m (C-N); m/z (ESI+) 269.4 ([M+H]+, 90%), 391.4 ([M+Na]+, 100%), HRMS (ESI+) 
found [M+Na]+ 391.2431 [C17H32N6O3Na]+ requires 391.2428; (L) [α]D20 = +69.7 (c 0.33, CH3OH), (D) 
[α]D20 = −69.5 (c 0.50; CH3OH). 
H-L/D-αMv2-NHMe – S8 
From S7 (348 mg, 0.93 mmol) according to General Procedure B. S8 was 
obtained as a clear oil (319 mg, quant.). Rf 0.69 (19:1 DCM:MeOH); 
δH (500 MHz, CD3OD) 2.76 (3H, s, J = 4.5, NHCH3), 2.30 (1H, sep, J = 6.9, 
CH(CH3)2), 2.22 (1H, sep, J = 6.9, CH(CH3)2), 1.57 (3H, s, NHC(CH3)), 1.55 
(3H, s, NHC(CH3)), 1.08 (3H, d, J = 6.9, CH(CH3)2), 1.04 (3H, d, J = 6.9, 
CH(CH3)2), 1.00 (3H, d, J = 6.9, CH(CH3)2), 0.92 (3H, d, J = 6.9, CH(CH3)2); 
δC (125 MHz, CDCl3) 173.7 (CONH), 169.1 (CONH), 64.6 (NHCCO), 64.1 (NHCCO), 35.1 (CH(CH3)2), 
34.7 (CH(CH3)2), 30.1 (NHCH3), 26.7 (NHC(CH3)), 18.6 (NHC(CH3)), 17.6 (CH(CH3)2), 17.5 (CH(CH3)2), 
17.0 (CH(CH3)2), 16.9 (CH(CH3)2); νmax/cm-1 3392m.br (N-H), 2968m (C-H), 1617s (C=O), 1463m (C-N), 
1403s (C-N); m/z (ESI+) 243.4 ([M+H]+, 100%), 365.4 ([M+Na]+, 20%), HRMS (ESI+) found [M+Na]+ 
365.2528 [C17H34N4O3Na]+ requires 365.2529; (L) [α]D20 = +18.4 (c 1.00; CH3OH), (D) [α]D20 = −18.4 
(c 1.00; CH3OH). 
Cbz-L-αMv2-Aib4-OH – S9 
Prepared as previously reported.4  
 





From S9 (72 mg, 0.10 mmol), EDC.HCl (25 mg, 0.13 mmol), DIPEA (23 µL, 0.13 mmol) and L-S8 (52 mg, 
0.15 mmol) according to General Procedure F. Crude 1a was purified by flash column chromatography 
(99:1 DCM:MeOH increasing to 90:10) to give the pure product as a white powder (64 mg, 0.06 mmol, 
61%). Rf 0.22 (19:1 DCM:MeOH); m.p. >250 °C; δH (500 MHz, CDCl3) 7.79 (1H, s, CONH), 7.77 (1H, s, 
CONH), 7.72 (1H, s, CONH), 7.63 (1H, s, CONH), 7.59 (1H, s, CONH), 7.38 (5H, m, PhH), 7.33 (2H, s, 
CONH), 7.00 (1H, s, CONH), 6.37 (1H, s, CONH), 5.21 (1H, s, CONH), 5.19 (1H, d, J = 12.2, PhCH2), 
5.03 (1H, d, J = 12.2, PhCH2), 2.80 (3H, d, J = 4.6, NHCH3), 2.15 (1H, sep, J = 6.7, CH(CH3)2), 2.07 (1H, 
sep, J = 6.8, CH(CH3)2), 1.86 (1H, sep, J = 6.7, CH(CH3)2), 1.53 (1H, m, CH(CH3)2), 1.51 (3H, s, 
NHC(CH3)2), 1.49 (6H, s, NHC(CH3)2), 1.49 (3H, s, NHC(CH3)2), 1.49 (6H, s, NHC(CH3)2), 1.47 (3H, s, 
NHC(CH3)2), 1.47 (3H, s, NHC(CH3)2), 1.47 (3H, s, NHC(CH3)2), 1.46 (3H, s, NHC(CH3)), 1.45 (6H, s, 
NHC(CH3)), 1.41 (3H, s, NHC(CH3)), 1.37 (3H, s, NHC(CH3)), 1.07 (3H, d, J = 6.7, CH(CH3)2), 1.02 (3H, 
d, J = 6.7, CH(CH3)2), 1.00 (3H, d, J = 6.8, CH(CH3)2), 0.97 (3H, d, J = 6.8, CH(CH3)2), 0.96 (3H, d, J = 7.1, 
CH(CH3)2), 0.95 (3H, d, J = 7.1, CH(CH3)2), 0.80 (3H, d, J = 6.5, NHC(CH3)2), 0.79 (3H, d, J = 6.4, 
CH(CH3)2); δC (100 MHz, CDCl3) 1794, 176.3, 175.9, 175.6, 175.6, 175.4, 173.4, 173.2, 172.6 (CONH), 
156.4 (CO2Bn), 135.8, 128.9, 128.9, 128.7 (Ar), 67.9 (PhCH2), 63.6, 63.5, 63.3, 62.5 (NHC(CH3)), 57.0, 56.9, 
56.8, 56.7 (NHC(CH3)2), 36.2, 35.9, 35.8, 35.8 (CH(CH3)2), 27.7, 27.6, 27.4, 27.4, 27.3 (NHC(CH3)2), 26.5 
(NHCH3), 23.0, 23.0, 22.9, 22.8 (NHC(CH3)2), 18.2, 18.1, 18.0, 17.5, 17.5, 17.4, 17.3, 17.2, 17.1, 16.7, 16.2, 
16.2 (CH(CH3)2); νmax/cm-1 3296m (N-H), 2982m (C-H), 1656s (C=O), 1531m (C-N); m/z (ESI+) 1065.9 
([M+Na]+, 100%), HRMS (ESI+) found [M+H]+ 1043.6816 [C53H91N10O11]+ requires 1043.6869; [α]D20 = 
+24.3 (c 1.00; (CH3Cl). 
Cbz-L-αMv2-Aib5-D-αMv2-NHMe – 1b 
From S9 (65 mg, 0.09 mmol), 
EDC.HCl (19 mg, 0.10 mmol), 
DIPEA (17 µL, 0.10 mmol) and D-
S8 (37 mg, 0.11 mmol) according to General Procedure F. Crude 1b was purified by flash column 
chromatography (96:4 DCM:MeOH increasing to 94:6) to give the pure product as a white powder (49 mg, 
0.05 mmol, 56%). Rf 0.23 (1:1 EtOAc:DCM); m.p. 254-256 °C; δH (400 MHz, CDCl3) 7.77 (1H, s, CONH), 
7.69 (1H, s, CONH), 7.60 (2H, s, CONH), 7.68 (1H, s, CONH), 7.57 (1H, s, CONH), 7.47 (1H, s, CONH), 
7.36 (5H, s, PhH), 7.20 (1H, s, CONH), 6.48 (1H, s, CONH), 5.60 (1H, s, CONH), 5.17 (1H, d, J = 12.1, 
PhCH2), 5.03 (1H, d, J = 12.1, PhCH2), 2.81 (3H, d, J = 4.5, NHCH3), 2.51 (1H, sep, J = 6.7, CH(CH3)2), 2.09 
(1H, sep, J = 6.7, CH(CH3)2), 1.91 (1H, m, CH(CH3)2), 1.60 (1H, sep, J = 6.8, CH(CH3)2), 1.52 (3H, s, 
NHC(CH3)2), 1.50 (6H, s, NHC(CH3)2), 1.49 (3H, s, NHC(CH3)2), 1.47 (6H, s, NHC(CH3)2), 1.47 (3H, s, 
NHC(CH3)2), 1.46 (6H, s, NHC(CH3)2), 1.45 (3H, s, NHC(CH3)2), 1.44 (3H, s, NHC(CH3)), 1.43 (3H, s, 





d, J = 6.8, CH(CH3)2), 0.95 (6H, m, CH(CH3)2), 0.95 (3H, d, J = 6.7, CH(CH3)2), 0.92 (6H, m, CHC(CH3)2), 
0.80 (6H, d, J = 6.7, CH(CH3)2); δC (125 MHz, CDCl3) 176.7, 175.7, 175.4, 175.3, 175.3, 175.1, 173.1, 172.7, 
172.5 (CONH), 156.3 (CO2Bn), 135.8, 128.7, 128.7, 128.5 (Ar), 67.6 (PhCH2), 64.2, 63.5, 63.2, 62.5 
(NHC(CH3)), 57.1, 57.0, 56.8, 56.8 (NHC(CH3)2), 36.1, 35.8, 35.7, 33.7 (CH(CH3)2), 27.0, 26.7, 26.7, 26.6, 
25.9 (NHC(CH3)2), 24.9 (NHCH3), 24.1, 23.7, 23.4, 23.2 (NHC(CH3)2), 18.4, 18.1, 18.0, 17.7, 17.7, 17.5, 
17.5, 17.4, 17.3, 17.3, 17.2 (CH(CH3)2); νmax/cm-1 3295m (N-H), 2982m (C-H), 1656s (C=O), 1531m 
(C-N); m/z (ESI+) 1044.2 ([M+H]+, 100%), 1066.2 ([M+Na]+, 90%), HRMS (ESI+) found [M+H]+ 1043.6869 
[C53H91N10O11]+ requires 1043.6869; [α]D20 = +23.6 (c 1.00; (CH3Cl). 
H-Aib2-OtBu – S10 
Prepared as previously reported.5  
 
Cbz-L-αMv-Aib2-OtBu – S11 
From L-S1 (941 mg, 3.55 mmol), TFFH (1410 mg, 5.36 mmol), pyridine 
(0.28 mL, 3.52 mmol), S10 (461 mg, 1.89 mmol) and DIPEA (0.33 mL. 
1.89 mmol) according to General Procedure C. Crude S11 was purified 
by flash column chromatography (DCM) and trituration (Et2O) to give the pure product (387 mg, 
0.79 mmol, 42%). Rf 0.43 (DCM); δH (500 MHz, CDCl3) 7.38-7.29 (5H, m, PhH), 5.16 (1H, d, J = 12.3, 
PhCH2), 5.03 (1H, d, J = 12.3, PhCH2), 2.04 (1H, sep, J = 6.9, CH(CH3)2), 1.56-1.40 (12H, m, NHC(CH3)2), 
1.44 (9H, s, C(CH3)3), 1.01 – 0.88 (9H, m, CH(CH3)2, NHC(CH3));  δC (125 MHz, CDCl3) 174.2 (CONH), 
173.7 (CONH), 172.9 (CO2C(CH3)3), 155.7 (CO2Bn), 136.1, 128.7, 128.5, 128.2 (Ar), 80.5 (C(CH3)3), 72.2 
(NHC(CH3)), 67.0 (PhCH2), 66.7 (NHC(CH3)2), 63.2 (NHC(CH3)2), 38.7 (CH(CH3)2), 27.9 (C(CH3)3), 25.0 
(NHC(CH3)2), 24.3 (NHC(CH3)2), 24.1 (NHC(CH3)2), 22.0 (NHC(CH3)), 17.2 (CH(CH3)2), 17.1 (CH(CH3)2); 
νmax/cm-1 3350m.br (N-H), 2975m (C-H), 2485s (C-H), 1783s (C=O), 1707s (C=O), 1518s (C-N), 1454m 
(C-O); m/z (ESI+) 492.4 ([M+H]+, 100%), 514.4 ([M+Na]+, 99%), HRMS (ESI+) found [M+H]+ 492.3066 
[C26H42N3O6]+ requires 492.3068; [α]D20 = +3.2 (c 1.25; CH3OH). 
 
H-L-αMv-Aib2-OtBu – S12 
From S11 (387 mg, 0.94 mmol) according to General Procedure B. S12 
obtained as a clear oil (283 mg, 0.80 mmol, 85%). Rf 0.00 (EtOAc); 
δH (500 MHz, CDCl3) 8.02 (1H, s, br, CONH), 7.36 (1H, s, br, CONH), 4.21 





(9H, s, C(CH3)3), 1.34 (3H, s, NHC(CH3)), 0.91 (3H, d, J = 6.9, CH(CH3)2), 0.87 (3H, d, J = 6.9, CH(CH3)2);  
δC (125 MHz, CDCl3) 176.7 (CO2C(CH3)3), 174.3 (CONH), 173.8 (CONH), 80.7 (C(CH3)3), 60.4 
(NHC(CH3)), 56.1 (NHC(CH3)2), 34.4 (CH(CH3)2), 26.7 (C(CH3)3), 23.8 (NHC(CH3)2), 23.7 (NHC(CH3)2), 
23.4 (NHC(CH3)2), 23.1 (NHC(CH3)), 16.3 (CH(CH3)2), 16.2 (CH(CH3)2); νmax/cm-1 3307w.br (N-H), 
2973m (C-H), 1731m (C=O), 1650s (C=O), 1507m (C-N); m/z (ESI+) 358.4 ([M+H]+, 100%), 380.4 
([M+Na]+, 80%), HRMS (ESI+) found [M+H]+ 358.2694 [C18H36N3O4]+ requires 358.2700; [α]D20 = −19.6 (c 
1.00; CH3OH). 
Cbz-L-αMv2-Aib2-OtBu – S13 
From L-S1 (387 mg, 1.46 mmol), TFFH (578 mg, 2.19 mmol), pyridine 
(118 µL, 1.46 mmol), S12 (178 mg, 0.73 mmol) and DIPEA (130 µL, 
0.73 mmol) according to General Procedure C. Crude S13 was 
purified by flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure product 
(190 mg, 0.31 mmol, 43%). Rf 0.30 (98:2 DCM:MeOH); δH (500 MHz, CDCl3) 7.39-7.33 (5H, m, PhH), 7.19 
(1H, s, br, CONH), 6.32 (1H, s, br, CONH), 5.18 (1H, d, J = 12.0, PhCH2), 5.15 (1H, s, br, CONH), 5.00 
(1H, d, J = 12.0, PhCH2), 2.81 (1H, s, CONH) 1.88 (2H, m, CH(CH3)2), 1.53 (3H, s, NHC(CH3)2), 1.49 (3H, 
s, NHC(CH3)2), 1.45 (6H, s, NHC(CH3)), 1.43 (12H, s, C(CH3)3, NHC(CH3)2), 1.40 (3H, s, NHC(CH3)2), 
0.97 (3H, d, J = 6.8, CH(CH3)2), 0.96 (3H, d, J = 6.9, CH(CH3)2), 0.79 (3H, d, J = 6.8, CH(CH3)2), 0.76 (3H, 
d, J = 6.9, CH(CH3)2); δC (125 MHz, CDCl3) 174.0 (CONH), 173.5 (CONH), 171.8 (CONH), 170.9 
(CO2C(CH3)3), 155.9 (CO2Bn), 135.7, 128.7 (Ar), 79.8 (C(CH3)3), 67.6 (PhCH2), 63.4 (NHC(CH3)2), 62.5 
(NHC(CH3)2), 56.8 (NHC(CH3)2), 56.0 (NHC(CH3)2), 36.0 (CH(CH3)2), 35.9 (CH(CH3)2), 27.9 (C(CH3)3), 
27.8 (NHC(CH3)2), 25.8 (NHC(CH3)2), 23.6 (NHC(CH3)), 23.1 (NHC(CH3)), 18.5 (CH(CH3)2), 18.1 (CH(C-
H3)2), 17.1 (CH(CH3)2), 17.0 (CH(CH3)2); νmax/cm-1 3330m.br (N-H), 2975m (C-H), 1783s (C=O), 1706s 
(C=O), 1668m (C=O), 1517m (C-N); m/z (ESI+) 606.0 ([M+H]+, 100%), HRMS (ESI+) found [M+H]+ 




Cbz-L-αMv2-Aib2-OH – S14 
To a stirred solution of S13 (50 mg, 0.08 mmol) and thioanisole 
(170 µL, 1.45 mmol) in DCM (0.20 mL) at 0 °C was added TFA 
(190 µL, 2.50 mmol) dropwise. The reaction was stirred at rt for 4 h 





DCM:MeOH increasing to 19:1) to give pure S14 as a white solid (40 mg, 0.08 mmol, quant.). Rf 0.16 (19:1 
DCM:MeOH); m.p. 249-251 °C; δH (500 MHz, CDCl3) 7.80 (1H, s, CONH), 7.61 (1H, s, CONH), 7.43-
7.30 (5H, m, PhH), 6.98 (1H, s, CONH), 5.20 (1H, d, J = 12.4, PhCH2), 5.04 (1H, d, J = 12.4, PhCH2), 1.93 
(1H, sep, J = 6.8, CH(CH3)2), 1.56 (1H, sep, J = 6.8, CH(CH3)2), 1.51 (6H, s, C(CH3)2CO2H), 1.46 (3H, s, 
NHC(CH3)2), 1.44 (3H, s, NHC(CH3)2), 1.42 NHC(CH3)), 1.37 (3H, s, NHC(CH3)2), 1.00 (3H, d, J = 6.8, 
CH(CH3)2), 0.95 (3H, d, J = 6.8, CH(CH3)2), 0.83 (3H, d, J = 6.8, CH(CH3)2), 0.80 (3H, d, J = 6.8, 
CH(CH3)2); δC (125 MHz, CDCl3) 181.5 (CO2H), 176.7 (CONH), 175.0 (CONH), 173.7 (CONH), 158.3 
(CO2Bn), 138.3, 129.6, 129.3 (Ar), 68.0 (PhCH2), 64.5 (NHC(CH3)), 63.9 (NHC(CH3)), 58.1 (NHC(CH3)2), 
55.1 (NHC(CH3)2), 37.0 (CH(CH3)2), 36.8 (CH(CH3)2), 28.1 (NHC(CH3)2), 26.4 (NHC(CH3)2), 24.3 
(NHC(CH3)), 23.5 (NHC(CH3)), 18.7 (CH(CH3)2), 18.4 (CH(CH3)2), 17.9 (CH(CH3)2), 17.5 (CH(CH3)2); 
νmax/cm-1 2980w.br (C-H), 1656s (C=O), 1416s (C-N); m/z (ESI−) 547.6 ([M−H]−, 100%), HRMS (ESI+) 
found [M+H]+ 549.3277 [C28H45N4O7]+ requires 549.3283; [α]D20 = +28.2 (c 1.00; CH3OH). 
N3-Aib2-L/D-αMv2-NHMe – S15 
From S6 (85 mg, 0.66 mmol), oxalyl chloride (62 µL, 0.73 mmol), S8 
(113 mg, 0.33 mmol) and Et3N (90 µL, 0.66 mmol) according to 
General Procedure A. Crude S15 was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure 
product as a white solid (97 mg, 0.21 mmol, 65%). Rf 0.50 (19:1 
DCM:MeOH); m.p. 156-158 °C; δH (400 MHz, CDCl3) 7.20 (1H, d, br, J 
= 4.4, CO2NHCH3), 6.86 (1H, s, CONH), 6.77 (1H, s, CONH), 6.43 (1H, s, CONH), 2.77 (3H, d, J = 4.4, 
CONHCH3), 2.02 (1H, sep, J = 6.9, CH(CH3)2), 1.93 (1H, sep, J = 6.9, CH(CH3)2), 1.53 (3H, s, 
CONHC(CH3)2) 1.50 (3H, s, CONHC(CH3)2), 1.48 (9H, s, N3C(CH3)2, CONHC(CH3), CONHC(CH3)), 
1.38 (3H, s, N3C(CH3)2), 0.93 (3H, d, J = 6.9, CH(CH3)2), 0.91 (3H, d, J = 6.9, CH(CH3)2), 0.90 (3H, d, J = 
6.9, CH(CH3)2), 0.90 (3H, d, J = 6.9, CH(CH3)2); δC (100 MHz, CDCl3) 174.6 (CONH), 173.7 (CONH), 
173.0 (CONH), 171.3 (CONH), 64.3 (NHC(CH3), 63.6 (NHC(CH3), 63.1 (CONHC(CH3)2), 57.6 
(N3C(CH3)2, 36.0 (CH(CH3)2), 35.9 (CH(CH3)2), 26.6 (N3C(CH3)2), 26.4 (NHCH3), 24.5 (N3C(CH3)2), 24.5 
(NHC(CH3)2), 23.7 (NHC(CH3)2), 18.8 (NHC(CH3)2), 17.7 (NHC(CH3)), 17.6 (CH(CH3)2), 17.3 (CH(CH3)2), 
17.2 (CH(CH3)2), 17.1 (CH(CH3)2); νmax/cm-1 3344m.br (N-H), 2972m (C-H), 2111s (N3), 1656m (C=O), 
1510m (C-N); m/z (ESI+) 476.4 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 476.2961 [C21H39N7O4Na]+ 
requires 476.2956; (L) [α]D20 = +20.4 (c 1.00; CH3OH), (D) [α]D20 = −20.3 (c 1.00; CH3OH). 
H-Aib2-L/D-αMv2-NHMe – S16 
From S15 (97 mg, 0.21 mmol) according to General Procedure B. 





(EtOAc); δH (400 MHz, CD3OD) 2.74 (3H, s, CONHCH3), 2.09-2.00 (2H, m, CH(CH3)2), 1.54 (3H, s, 
H2NC(CH3)2) 1.56 (3H, s, H2NC(CH3)2), 1.49 (3H, s, CONHC(CH3)2), 1.49 (3H, s, CONHC(CH3)2), 1.45 
(CONHC(CH3), 1.38 (CONHC(CH3), 1.03 (3H, d, J = 6.8, CH(CH3)2), 0.97 (3H, d, J = 6.8, CH(CH3)2), 0.95 
(3H, d, J = 7.0, CH(CH3)2), 0.93 (3H, d, J = 7.0, CH(CH3)2); δC (125 MHz, CD3OD) 176.8 (CONHCH3), 
176.5 (CONH), 173.4 (CONH), 173.3 (CONH), 64.9 (NHC(CH3), 64.8 (NHC(CH3), 64.5 (CONHC(CH3)2), 
58.6 (H2NC(CH3)2), 37.1 (CH(CH3)2), 36.7 (CH(CH3)2), 26.5 (H2NC(CH3)2), 26.1 (CONHCH3), 25.6 
(CONHC(CH3)2), 25.5 (CONHC(CH3)2), 23.9 CONHC(CH3), 18.3 (H2NC(CH3)2, 18.3 (CONHC(CH3), 
18.2 (CH(CH3)2), 17.7 (CH(CH3)2), 17.6 (CH(CH3)2), 17.6 (CH(CH3)2); νmax/cm-1 3356m.br (N-H), 2970m 
(C-H), 2485s (C-H), 1655s (C=O), 1519w (C-N), 1409m (C-N); m/z (ESI+) 428.4 ([M+H]+, 100%), HRMS 
(ESI+) found [M+Na]+ 450.3050 [C21H41N5O4Na]+ requires 450.3051; (L) [α]D20 = +14.8 (c 1.00, CH3OH), 
(D) [α]D20 = −14.8 (c 1.00, CH3OH). 
Cbz-Ac3C-Aib2-L/D-αMv2-NHMe – S17 
From Cbz-Ac3C-OH (99 mg, 0.42 mmol), TFFH (166 mg, 
0.63 mmol), pyridine (34 µL, 0.42 mmol), S16 (91 mg, 
0.21 mmol) and DIPEA (37 µL, 0.21 mmol) according to 
General Procedure C. Crude S17 was purified by flash 
column chromatography (99:1 DCM:MeOH increasing to 
19:1) to give the pure product (110 mg, 0.17 mmol, 80%). Rf 
0.30 (94:6 DCM:MeOH); m.p. 248-250 °C; δH (500 MHz, CDCl3) 7.46-7.06 (10H, m, PhH, CONH), 6.87 
(1H, s, br, NHCH3), 5.21 (1H, d, J = 12.0, PhCH2), 5.06 (1H, d, J = 12.0, PHCH2), 2.73 (3H, s, NHCH3), 2.01 
(1H, sep, J = 6.1, CH(CH3)2), 2.00 (1H, sep, J = 6.1, CH(CH3)2), 1.88-1.16 (22H, m, C(CH2-CH2), 
NHC(CH3)2, NHC(CH3)2, NHC(CH3), NHC(CH3)), 0.98 (6H, d, J = 6.1, CH(CH3)2), 0.90 (6H, d, J = 6.1, 
CH(CH3)2); δC (125 MHz, CDCl3) 183.8 (CONH), 175.9 (CONH), 175.7 (CONH), 174.4 (CONH), 173.3 
(CONH), 157.8 (CO2Bn), 136.8, 128.7, 128.5, 128.0 (Ar), 63.4 (NHC(CH3)), 63.4 (NHC(CH3)), 56.6 
(PhCH2), 55.6 (NHC(CH3)2, NHC(CH3)2), 36.8 (C(CH2-CH2)), 35.8 (CH(CH3)2), 35.7 (CH(CH3)2), 31.1 
(NHCH3), 27.3 (NHC(CH3)2), 27.1 (NHC(CH3)2), 27.0 (NHC(CH3)2), 26.6 (NHC(CH3)2), 23.3 (NHC(CH3), 
23.0 (NHC(CH3), 17.9 (CH(CH3)2), 17.8 (CH(CH3)2), 17.5 (CH(CH3)2), 17.4 (CH(CH3)2), 17.0 (C(CH2-CH2), 
15.9 (C(CH2-CH2); νmax/cm-1 3336m (N-H), 3268m (N-H), 2973m (C-H), 1658s (C=O), 1529m (C-N); m/z 
(ESI+) 345.8 ([M+H]+, 100%), 667.8 ([M+Na]+, 60%), HRMS (ESI+) found [M+H]+ 645.3968 [C33H53N6O7]+ 
requires 645.3970; (L) [α]D20 = +39.6 (c 0.95; CH3OH, (D) [α]D20 = −39.6 (c 1.00; CH3OH). 
H-Ac3C-Aib2-L/D-αMv2-NHMe – S18 
From S17 (110 mg, 0.17 mmol) according to General 





0.17 mmol, quant.). Rf 0.00 (EtOAc); m.p. >190 °C (decomp); δH (400 MHz, CD3OD) 2.75 (3H, s, 
NHCH3), 2.15 (1H, sep, J =  6.8, CH(CH3)2), 2.06 (1H, sep, J = 6.8, CH(CH3)2), 1.46 (3H, s, NHC(CH3)2), 
1.45 (3H, s, NHC(CH3)2), 1.43 (6H, s, NHC(CH3)2), 1.36 (3H, s, NHC(CH3)), 1.30 (3H, s, NHC(CH3)), 
1.26-1.23 (2H, m, C(CH2-CH2)), 1.02 (3H, d, J = 6.8, CH(CH3)2), 0.98 (3H, d, J = 6.8, CH(CH3)2), 0.93-0.87 
(8H, m, CH(CH3)2, C(CH2-CH2)); δC (100 MHz, CDCl3) 177.7 (CONH), 177.5 (CONH), 177.5 (CONH), 
176.3 (CONH), 175.5 (CONH), 64.7 (NHC(CH3)), 64.6 (NHC(CH3)), 57.7 (NHC(CH3)2), 57.6 (NHC(CH-
3)2), 37.0 (C(CH2-CH2)), 36.9 (CH(CH3)2), 36.5 (CH(CH3)2), 27.4 (NHCH3), 26.6 (NHC(CH3)2), 26.5 
(NHC(CH3)2), 24.2 (NHC(CH3)), 23.4 (NHC(CH3)), 18.3 (C(CH2-CH2)), 18.2 (C(CH2-CH2)), 17.9 
(CH(CH3)2), 17.5 (CH(CH3)2), 17.1 (CH(CH3)2), 16.4 (CH(CH3)2); νmax/cm-1 3338m.br (N-H), 2970m (C-H), 
1646s (C=O), 1424s (C-N); m/z (ESI+) 512 ([M+H]+, 100%), 534 ([M+Na]+, 80%), HRMS (ESI+) found 
[M+H]+ 511.3598 [C25H47N6O5]+ requires 321.3602; (L) [α]D20 = +9.2 (c 1.00; CH3OH), (D) [α]D20 = −8.6 
(c 1.01; CH3OH). 
Cbz-L-αMv2-Aib2-Ac3C-Aib2-L-αMv2-NHMe – 2a 
From S14 (50 mg, 0.09 mmol), 
EDC.HCl (26 mg, 0.14 mmol), 
DIPEA (24 µL, 0.14 mmol) and L-
S18 (47 mg, 0.09 mmol) according to General Procedure F. Crude 2a was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure product as a white powder (38 mg, 
0.04 mmol, 44%). Rf 0.21 (19:1 DCM:MeOH); m.p. >250 °C; δH (500 MHz, CDCl3) 8.25 (1H, s, CONH), 
7.94 (1H, s, CONH), 7.78 (1H, s, CONH), 7.68 (1H, s, CONH), 7.43 (1H, s, CONH), 7.37 (6H, s, PhH, 
CONH), 7.22 (1H, s, CONH), 7.01 (1H, s, CONH), 6.42 (1H, s, CONH), 5.48 (1H, s, CONH), 5.18 (1H, d, 
J = 12.1, PhCH2), 5.03 (1H, d, J = 12.1, PhCH2), 2.78 (3H, d, J = 4.5, NHCH3), 2.12 (1H, sep, J = 7.2, 
CH(CH3)2), 1.98 (1H, sep, J = 6.7, CH(CH3)2), 1.87 (1H, sep, J = 6.9, CH(CH3)2), 1.71-1.63 (3H, m, C(CH2-
CH2), CH(CH3)2), 1.55 (3H, s, NHC(CH3)2), 1.51 (8H, s, NHC(CH3)2, C(CH2-CH2)), 1.50 (6H, s, 
NHC(CH3)2), 1.48 (3H, s, NHC(CH3)2), 1.47 (6H, s, NHC(CH3)2), 1.43 (3H, s, NHC(CH3)), 1.41 (3H, s, 
NHC(CH3)), 1.37 (3H, s, NHC(CH3)), 1.36 (3H, s, NHC(CH3)), 1.02 (3H, d, J = 6.7, CH(CH3)2), 1.01 (3H, 
d, J = 6.9, CH(CH3)2), 0.98 (3H, d, J = 6.9, CH(CH3)2), 0.95 (3H, d, J = 6.7, CH(CH3)2), 0.94-0.90 (6H, m, 
CH(CH3)2), 0.82 (3H, d, J = 6.8, CH(CH3)2), 0.78 (3H, d, J = 6.8, CH(CH3)2); δC (125 MHz, CDCl3) 178.2, 
175.9, 175.8, 175.6, 175.2, 173.4, 173.0, 172.8, 172.5 (CONH), 156.5 (CO2Bn), 135.8, 128.9, 128.9, 128.7 
(Ar), 67.9 (PhCH2), 63.6, 63.6, 63.4, 62.5 (NHC(CH3)), 57.2, 57.1, 56.8, 56.7 (NHC(CH3)2), 36.1 (C(CH2-
CH2)), 35.9, 35.9, 35.9, 35.4 (CH(CH3)2), 27.7, 27.7, 27.4, 27.1 (NHC(CH3)2), 26.5 (NHCH3), 23.2, 22.9, 
22.8, 21.2 (NHC(CH3)2), 18.3, 18.1, 17.9, 17.9 (NHC(CH3)), 17.6, 17.5, 17.4, 17.3, 17.3, 17.2, 17.1 





(C=O), 1528m (C-N); m/z (ESI+) 1064.8 ([M+Na]+, 100%), HRMS (ESI+) found [M+H]+ 1041.6697 [C53H-
89N10O11]+ requires 1041.6707; [α]D20 = +48.9 (c 1.12; CH3OH). 
Cbz-L-αMv2-Aib2-Ac3C-Aib2-D-αMv2-NHMe – 2b 
From S14 (50 mg, 0.09 mmol), 
EDC.HCl (26 mg, 0.14 mmol), 
DIPEA (24 µL, 0.14 mmol) and D-
S18 (47 mg, 0.09 mmol) according to General Procedure F. Crude 2b was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure product as a white powder (38 mg, 
0.04 mmol, 44%). Rf 0.22 (19:1 DCM:MeOH); m.p. 243-245 °C; δH (500 MHz, CDCl3) 8.08 (1H, s, 
CONH), 7.90 (1H, s, CONH), 7.70 (1H, s, CONH), 7.65 (1H, s, CONH), 7.40-7.34 (7H, m, PhH, CONH), 
7.12 (1H, s, CONH), 7.11 (1H, s, CONH), 6.42 (1H, s, CONH), 6.42 (1H, s, CONH), 5.39 (1H, s, CONH), 
5.18 (1H, d, J = 12.1, PhCH2), 5.03 (1H, d, J = 12.1, PhCH2), 2.80 (3H, d, J = 4.6, NHCH3), 2.36 (1H, m, 
CH(CH3)2), 2.09 (1H, sep, J = 6.8, CH(CH3)2), 1.89 (1H, sep, J = 6.8, CH(CH3)2), 1.79-1.71 (4H, m, C(CH2-
CH2)), 1.58 (1H, m, CH(CH3)2), 1.54 (3H, s, NHC(CH3)2), 1.53 (3H, s, NHC(CH3)2), 1.52 (3H, s, 
NHC(CH3)2), 1.51 (3H, s, NHC(CH3)2), 1.50 (3H, s, NHC(CH3)2), 1.49 (3H, s, NHC(CH3)2), 1.47 (3H, s, 
NHC(CH3)2), 1.45 (3H, s, NHC(CH3)2), 1.43 (3H, s, NHC(CH3)), 1.42 (3H, s, NHC(CH3)), 1.37 (3H, s, 
NHC(CH3)), 1.35 (3H, s, NHC(CH3)), 1.00-0.90 (18H, m, CH(CH3)2), 0.82 (3H, d, J = 6.8, CH(CH3)2), 0.78 
(3H, d, J = 6.8, CH(CH3)2); δC (100 MHz, CDCl3) 177.6, 176.1, 176.0, 175.8, 175.1, 173.4, 172.9, 172.8, 
172.6 (CONH), 156.5 (CO2Bn), 135.8, 128.9, 128.9, 128.7 (Ar), 67.8 (PhCH2), 64.1, 63.6, 63.3, 62.5 
(NHC(CH3)), 57.3, 57.1, 56.9, 56.8 (NHC(CH3)2), 36.1, 35.9, 35.8, 35.1 (CH(CH3)2), 34.1 (C(CH2-CH2)), 
27.2, 26.9 (NHC(CH3)2), 26.6 (NHCH3), 26.0, 25.6, 25.4, 24.8, 23.1, 23.1 (NHC(CH3)2), 18.4, 18.0, 17.9, 17.7 
(NHC(CH3)), 17.6, 17.6, 17.5, 17.4, 17.3, 17.43 17.2, 17.2 (CH(CH3)2), 16.4, 15.9 (C(CH2-CH2)); νmax/cm-1 
3295m (N-H), 2978m (C-H), 1657s (C=O), 1530m (C-N); m/z (ESI+) 1063.8 ([M+Na]+, 100%), HRMS (ESI+) 
found [M+NH4]+ 1058.6970 [C53H92N11O11]+ requires 1058.6972; [α]D20 = +23.6 (c 1.00; CH3OH). 
 
N3-Aib-L/D-αMv-NHMe – S19 
From S6 (893 mg, 6.92 mmol), oxalyl chloride (0.62 mL, 7.38 mmol), S3 (664 mg, 
4.60 mmol) and Et3N (0.97 mL, 6.92 mmol) according to General Procedure A. 
Crude S19 was purified by flash column chromatography (99:1 DCM:MeOH 
increasing to 19:1) to give the pure compound as a clear oil (740 mg, 2.90 mmol, 
63%). Rf 0.43 (19:1 DCM:MeOH); δH (500 MHz, CDCl3) 7.00 (1H, s, br, CONH), 





CH(CH3)2), 1.46 (3H, s, NHC(CH3)), 1.45 (3H, s, N3C(CH3)2), 1.42 (3H, s, N3C(CH3)2), 0.85 (3H, d, J = 6.9, 
CH(CH3)2), 0.81 (3H, d, J = 6.9, CH(CH3)2); δC (125 MHz, CDCl3) 173.8 (CONH), 172.3 (CONH), 64.6 
(N3C(CH3)2), 63.9 (NHC(CH3)), 33.4 (CH(CH3)2), 26.5 (NHCH3), 24.4 (N3C(CH3)2), 24.3 (N3C(CH3)2), 17.9 
(NHC(CH3)), 17.2 (CH(CH3)2), 17.1 (CH(CH3)2); νmax/cm-1 3350m.br (N-H), 2971m (C-H), 2111s (N3), 
1651s (C=O), 1507m (C-N); m/z (ESI+) 278.2 ([M+Na]+, 95%), 533.4 ([2M+Na]+, 100%), HRMS (ESI+) found 
[M+Na]+ 278.1579 [C11H21N5O2Na]+ requires 278.1587; (L) [α]D20 = +20.6 (c 0.99, CH3OH), (D) [α]D20 = 
−20.4 (c 1.10; CH3OH). 
H-Aib-L/D-αMv-NHMe – S20 
From S19 (420 mg, 1.64 mmol) according to General Procedure B. S20 
obtained as a white powder (376 mg, quant.). Rf 0.00 (EtOAc); m.p. 99-101 °C; 
δH (500 MHz, CD3OD) 2.76 (3H, d, J = 4.8, NHCH3), 2.16 (1H, sep, J = 6.8, 
CH(CH3)2), 1.48 (3H, s, NHC(CH3)), 1.40 (3H, s, H2NC(CH3)2), 1.37 (3H, s, 
H2NC(CH3)2), 1.02 (3H, d, J = 6.8, CH(CH3)2), 0.95 (3H, d, J = 6.8, CH(CH3)2); δC 
(125 MHz, CD3OD) 178.4 (CONHCH3), 176.2 (CONH), 63.9 (NHC(CH3)), 56.4 
(H2NC(CH3)2), 36.4 (CH(CH3)2), 27.9 (NHC(CH3)), 27.7 (H2NC(CH3)2), 26.6 (NHCH3), 17.6 (NHC(CH3)), 
17.5 (CH(CH3)2), 17.4 (CH(CH3)2); νmax/cm-1 3308m.br (N-H), 2966m (C-H), 2467m (C-H), 1641s (C=O), 
1510m (C-N), 1456m (C-N); m/z (ESI+) 230.2 ([M+H]+, 100%), HRMS (ESI+) found [M+H]+ 230.1858 
[C11H24N3O2]+ requires 230.1863; (L) [α]D20 = +2.0 (c 0.99, CH3OH), (D) [α]D20 = −2.0 (c 1.00; CH3OH). 
N3-Aib4-OH – S21 




N3-Aib5-D-αMv-NHMe – S22 
From S21 (150 mg, 0.39 mmol), EDC.HCl (113 mg, 
0.59 mmol), Et3N (62 µL, 0.59 mmol) and D-S20 (138 mg, 
0.59 mmol) according to General Procedure F. Crude 
S22 was purified by flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure 
compound as a white powder (43 mg, 0.07 mmol, 19%). Rf 0.12 (19:1 DCM:MeOH); m.p. 249-251 °C; 





CONH), 6.90 (1H, s, CONH), 6.23 (1H, s, CONH), 2.80 (3H, d, J = 4.4, NHCH3), 2.15 (1H, sep, J = 6.8, 
CH(CH3)2), 1.56 (3H, s, NHC(CH3)2), 1.54 (3H, s, NHC(CH3)2), 1.50 (3H, s, NHC(CH3)2), 1.49 (6H, s, 
NHC(CH3)2), 1.48 (3H, s, NHC(CH3)2), 1.47 (3H, s, NHC(CH3)2), 1.46 (3H, s, NHC(CH3)2), 1.45 (6H, s, 
NHC(CH3)2), 1.38 (3H, s, NHC(CH3)), 0.99 (3H, d, J = 6.8, CH(CH3)2), 0.96 (3H, d, J = 6.8, CH(CH3)2); 
δC (100 MHz, CDCl3) 175.4 (CONH), 175.4 (CONH), 174.4 (CONH), 173.5 (CONH), 173.3 (CONH), 
173.3 (CONH), 64.1 (N3C(CH3)2), 63.4 (NHC(CH3)), 57.2 (NHC(CH3)2), 57.0 (NHC(CH3)2), 57.0 
(NHC(CH3)2), 56.9 (NHC(CH3)2), 35.8 (CH(CH3)2), 27.3 (N3C(CH3)2), 27.2 (N3C(CH3)2), 26.5 (NHC(CH3)2, 
NHCH3), 26.1 (NHC(CH3)2), 24.5 (NHC(CH3)2), 24.4 (NHC(CH3)2), 23.8 (NHC(CH3)2), 23.6 (NHC(CH3)2), 
23.5 (NHC(CH3)2, NHC(CH3)), 17.8  (CH(CH3)2), 17.3 (CH(CH3)2); νmax/cm-1 3322m.br (N-H), 2975w 
(C-H), 2112m (N3), 1655s (C=O), 1522m (C-N); m/z (ESI+) 596.5 ([M+H]+, 100%), HRMS (ESI+) found 
[M+Na]+ 618.3704 [C27H49N9O6Na]+ requires 618.3704; [α]D20 = −25.2 (c 1.00; CH3OH). 
H-Aib5-D-αMv-NHMe – S23 
From S22 (40 mg, 0.07 mmol) according to General 
Procedure B. S23 was obtained as a white powder 
(37 mg, 0.07 mmol, quant.). Rf 0.29 (19:1 DCM:MeOH); 
m.p. 210-212 °C; δH (400 MHz, CDCl3) 8.29 (2H, s, NH2), 7.77 (1H, m, CONH), 7.69 (1H, m, CONH), 
7.35 (1H, m, CONH), 6.99 (1H, m, CONH), 6.90 (1H, s, br, CONH), 6.59 (1H, s, br, CONH), 2.78 (3H, d, 
J = 4.5, NHCH3), 2.14 (1H, m, J = 6.8, CH(CH3)2), 1.56-1.31 (33H, m, NHC(CH3)2, NHC(CH3)), 0.98 (3H, 
d, J = 6.8, CH(CH3)2), 0.92 (3H, d, J = 6.4, CH(CH3)2); δC (100 MHz, CDCl3) 178.8 (CONHCH3), 175.9 
(CONH), 175.7 (CONH), 174.7 (CONH), 174.3 (CONH), 173.9 (CONH), 63.2 (NHC(CH3)), 57.1 
(NHC(CH3)2), 56.8 (NHC(CH3)2), 56.7 (NHC(CH3)2), 56.3 (NHC(CH3)2), 54.8 (H2NC(CH3)2), 35.8 
(CH(CH3)2), 29.0 (H2NC(CH3)2), 28.9 (H2NC(CH3)2), 27.4 (NHC(CH3)2), 26.9 (NHC(CH3)2), 26.6 
(NHC(CH3)2, NHCH3), 26.4 (NHC(CH3)2), 23.5 (NHC(CH3)2), 23.4 (NHC(CH3)2), 23.3 (NHC(CH3)2, 
NHC(CH3)), 17.9  (CH(CH3)2), 17.4 (CH(CH3)2); νmax/cm-1 3308m (N-H), 2980m (C-H), 1757s (C=O), 
1527m (C-N); m/z (ESI+) 570.5 ([M+H]+, 100%), HRMS (ESI+) found [M+Na]+ 592.3798 [C27H51N7O6Na]+ 
requires 592.3799; [α]D20 = −12.8 (c = 1.00; CH3OH). 
H-Bip-OtBu – S24 
From Cbz-Bip-OtBu (428 mg, 0.96 mmol) according to General Procedure B. S24 was 
obtained as a pale yellow powder (292 mg, 0.94 mmol, 98%). δH (400 MHz, CDCl3) 7.45-
7.27 (8H, m, ArH), 3.02 (2H, d, J = 13.5, ArCH2), 2.56-2.41 (2H, m, ArCH2), 1.46 (9H, s, 
C(CH3)3); δC (100 MHz, CDCl3) 174.2 (CO2), 140.7, 130.3, 128.5, 127.6 (Ar), 82.0 (C(CH3)3), 68.6 





N3-Aib-Bip-OtBu – S25 
From S6 (77 mg, 0.60 mmol), oxalyl chloride (54 μL, 0.64 mmol), S24 (100 mg, 
0.40 mmol) and Et3N (170 µL, 1.20 mmol) according to General Procedure A. 
Crude S25 was purified by flash column chromatography (9:1 PE:EtOAc) obtained as a 
glassy solid (115 mg, 0.27 mmol, 68%). Rf 0.57 (4:1 PE:EtOAc); m.p. 131-133 °C; δH (400 MHz, CDCl3) 
7.46-7.37 (4H, m, ArH), 7.32 (2H, q, J = 7.1, ArH), 7.20 (2H, d, J = 7.1, ArH), 6.72 (1H, s, CONH), 3.33-
2.29 (2H, m, ArCH2), 3.15 (2H, d, J = 11.3, ArCH2), 1.56 (6H, s, NHC(CH3)2), 1.47 (9H, s, C(CH3)3); 
δC (100 MHz, CDCl3) 171.5 (CO2) 170.5 (CONH), 140.8, 135.2, 130.0, 128.4, 127.9, 127.8 (Ar), 81.6 
(C(CH3)3), 69.1 (ArCH2C), 64.5 (N3C(CH3)2), 40.1 (ArCH2), 28.0 (C(CH3)3), 24.5 (N3C(CH3)2); νmax/cm-1 
3411w (N-H), 2978m (C-H), 2111s (N3) 1736s (C=O), 1505s (C-N); m/z (ESI+) 421.3 ([M+H]+, 100%), 
443.3 ([M+Na]+, 50%), HRMS (ESI+) found [M+Na]+ 443.2070 [C24H28N4O3Na]+ requires 443.2059. 
N3-Aib-Bip-OH – S26 
From S25 (115 mg, 0.27 mmol) according to General Procedure D. Crude S26 was 
purified by flash column chromatography (97:3 DCM:MeOH increasing to 19:1) to give 
the pure product as a clear oil (87 mg, 0.24 mmol, 89%). Rf 0.27 (19:1 DCM:MeOH); 
δH (500 MHz, CDCl3) 9.34 (1H, s, br, CO2H), 7.47-7.41 (4H, m, ArH), 7.34 (2H, dd, J = 6.0, ArH), 7.30-7.23 
(2H, m, ArH), 6.89 (1H, s, CONH), 3.46-2.29 (2H, m, ArCH2), 3.34-3.12 (2H, m, ArCH2), 1.57 (6H, s, 
NHC(CH3)2); δC (125 MHz, CDCl3) 176.5 (CO2H) 172.6 (CONH), 140.7, 134.6, 130.0, 128.5, 128.1, 127.9 
(Ar), 68.8 (ArCH2C), 64.3 (N3C(CH3)2), 38.9 (ArCH2), 24.4 (N3C(CH3)2); νmax/cm-1 2978s.br (O-H, N-H, 
C-H), 2112s (N3) 1715m (C=O), 1680m (C=O), 1509m (C-N); m/z (ESI−) 365.2 ([M+H]+, 100%), HRMS 





N3-Aib-Bip-Aib5-D-αMv-NHMe – S27 
From S26 (46 mg, 0.13 mmol), EDC.HCl 
(36 mg, 0.19 mmol), Et3N (34 µL, 0.19 mmol) 
and S23 (38 mg, 0.07 mmol) according to 
General Procedure F. Crude S27 was 





as a clear film (36 mg, 0.04 mmol, 57%). Rf 0.27 (19:1 DCM:MeOH); m.p. 230-231 °C; δH (400 MHz, 
CDCl3) 7.77 (1H, s, CONH), 7.73 (1H, s, CONH), 7.59 (1H, s, CONH), 7.51-7.30 (8H, m, ArH), 7.23-7.12 
(3H, m, CONH), 7.02 (1H, s, CONH), 6.82 (1H, s, CONH), 3.33 (1H, m, ArCH2), 3.08 (1H, d, J = 12.0, 
ArCH2), 2.96-2.25 (2H, m, ArCH2), 2.77 (3H, d, J = 4.5, NHCH3), 2.13 (1H, m, CH(CH3)2), 1.60 (6H, s, 
NHC(CH3)2), 1.51 (3H, s, NHC(CH3)2), 1.48 (12H, s, NHC(CH3)2, 1.47 (3H, s, NHC(CH3)2), 1.46 (3H, s, 
NHC(CH3)2), 1.45-1.39 (9H, m, NHC(CH3)2), NHC(CH3), N3C(CH3)2), 1.39-1.28 (N3C(CH3)2), 0.99 (3H, d, 
J = 6.6, CH(CH3)2), 0.93 (3H, d, J = 6.6, CH(CH3)2); δC (100 MHz, CDCl3) 176.1 (CONH), 175.7 (CONH), 
175.5 (CONH), 175.2 (CONH), 174.8 (CONH), 174.4 (CONH), 173.5 (CONH), 171.9 (CONH), 140.7, 
140.5, 135.0, 133.4, 130.2, 130.1, 129.4, 128.7, 128.6, 128.5, 128.1, 128.0 (Ar), 69.5 (ArCH2C), 64.1 
(N3C(CH3)2), 63.2 (NHC(CH3)), 57.1 (NHC(CH3)2), 57.1 (NHC(CH3)2), 56.9 (NHC(CH3)2), 56.8 
(NHC(CH3)2), 56.7 (NHC(CH3)2), 35.8 (ArCH2), 29.8 (CH(CH3)2), 27.5-26.4 (N3C(CH3)2, NHC(CH3)2, 
NHCH3), 24.7-24.3 (NHC(CH3)2), 23.7-22.9 (NHC(CH3)2, NHC(CH3)), 17.9 (CH(CH3)2), 17.4 (CH(CH3)2); 
νmax/cm-1 3305m (N-H), 2982w (C-H), 2114m (N3), 1656m (C=O), 1526m (C-N); m/z (ESI+) 1159.8 
([M+H]+, 100%), HRMS (ESI+) found [M+Na]+ 938.5182 [C47H69N11O8Na]+ requires 938.5228; [α]D20 = 
−49.6 (c 1.00; CH3OH). 
H-Aib-Bip-Aib5-D-αMv-NHMe – S28 
From S27 (36 mg, 0.04 mmol) according to 
General Procedure B. S28 was obtained 
as a clear film (21 mg, 0.02 mmol, 58%). Rf 
0.17 (19:1 DCM:MeOH); δH (500 MHz, 
CDCl3) 8.54 (2H, s, br, NH2), 7.86-.6.93 (14H, m, ArH, CONH), 6.83 (1H, s, br, CONH), 6.34 (1H, s, br, 
CONH), 3.74-2.95 (2H, m, ArCH2), 2.79 (3H, d, J = 4.5, NHCH3), 2.21-2.09 (3H, m, ArCH2, CHCH3)2), 
1.64-1.20 (36H, s, NHC(CH3)2, NHC(CH3)), 0.99 (3H, d, J = 6.5, CH(CH3)2), 0.93 (3H, d, J = 6.2, 
CH(CH3)2); δC (125 MHz, CDCl3) 179.2 (CONH), 176.2 (CONH), 175.8 (CONH), 175.7 (CONH), 175.4 
(CONH), 174.9 (CONH), 174.7 (CONH), 174.7 (CONH), 140.5, 135.7, 133.8, 130.2, 129.5, 128.6, 128.5, 
128.4, 128.3, 127.9 (Ar), 69.1 (ArCH2C), 63.2 (NHC(CH3)), 57.4 (NHC(CH3)2), 57.1 (NHC(CH3)2), 56.9 
(NHC(CH3)2), 56.8 (NHC(CH3)2), 56.6 (NHC(CH3)2), 55.0 (H2NC(CH3)2), 35.9 (ArCH2), 29.8 (CH(CH3)2), 
29.1 (H2NC(CH3)2), 27.7-26.3 (H2NC(CH3)2, NHC(CH3)2, NHCH3), 23.7-22.7 (NHC(CH3)2, NHC(CH3)), 
17.9 (CH(CH3)2), 17.4 (CH(CH3)2); νmax/cm-1 3328m.br (N-H), 2971m (C-H), 1667s (C=O), 1512m (C-N); 
m/z (ESI+) 891.5 ([M+H]+, 100%), HRMS (ESI+) found [M+Na]+ 912.5279 [C47H71N9O8]+ requires 912.5323; 
[α]D20 = −74.0 (c 1.00; CH3OH). 





From L-S1 (12 mg, 0.05 mmol), 
TFFH (18 mg, 0.07 mmol), pyridine 
(4 µL, 3.04 mmol), S28 (21 mg, 
0.02 mmol) and DIPEA (4 L. µL, 
0.02 mmol) according to General Procedure C. Crude 4a was purified by flash column chromatography 
(99:1 DCM:MeOH increasing to 19:1) to give the pure product (16 mg, 0.01 mmol, 62%). Rf 0.30 (19:1 
DCM:MeOH); m.p. >250 °C; δH (400 MHz, CDCl3) 7.80-6.96 (21H, m, ArH, CONH), 6.52 (1H, s, 
CONH), 5.43 (1H, s, CONH) 5.22-4.58 (2H, m, PhCH2), 3.34-1.89 (9H, m, ArCH2, NHCH3, CH(CH3)2), 
1.63-1.08 (42H, m, NHC(CH3)2, NHC(CH3)), 1.05-0.76 (12H, m, CH(CH3)2); δC (125 MHz, 
CD2Cl2/CD3OD) 177.3 (CONH), 177.3 (CONH), 176.8 (CONH), 176.7 (CONH), 176.7 (CONH), 176.4 
(CONH), 176.1 (CONH), 176.0 (CONH), 176.0 (CONH), 157.0 (CO2Bn), 141.4, 136.8, 130.5, 129.1, 128.8, 
128.6, 128.6, 128.4, 128.2, 128.0 (Ar), 70.4 (ArCH2C), 67.4 (PhCH2), 63.7 (NHC(CH3)), 57.7-57.1 
(NHC(CH3)2), 36.5-35.1 (ArCH2), 32.5 (NHC(CH3)), 30.4-22.8 (NHCH3, NHC(CH3)2, NHC(CH3)), 18.1-17.2 
(CH(CH3)2); νmax/cm-1 3303w (N-H), 2927w (C-H), 1653s (C=O), 1521m (C-N); m/z (ESI+) 1159.7 
([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 1159.6530 [C61H88N10O11Na]+ requires 1159.6526; [α]D20 = 
−5.00 (c 0.10; CH3OH). 
Cbz-L-αMv-Aib3-OtBu – S29 
Prepared as previously reported.7  
 
Cbz-L-αMv-Aib3-OH – S30 
From S29 (745 mg, 1.29 mmol) according to General Procedure D. 
Crude S30 was purified by flash column chromatography (99:1 
DCM:MeOH increasing to 19:1) to give the pure product as white 
powder (593 mg, 1.14 mmol, 88%). Rf 0.32 (19:1 DCM:MeOH); m.p. 176-178 °C; δH (500 MHz, CDCl3) 
7.57 (2H, s, CONH), 7.41-7.30 (5H, m, PhH), 6.41 (1H, s, br, CONH), 5.39 (1H, s, br, CONH), 5.18 (1H, d, 
J = 12.2, PhCH2), 5.03 (1H, d, J = 12.2, PhCH2), 1.94 (1H, m, CH(CH3)2), 1.60 (3H, s, NHC(CH3)2), 1.55 
(3H, s, NHC(CH3)2), 1.46 (3H, s, NHC(CH3)2), 1.43 (6H, s, NHC(CH3)2), 1.39 (3H, s, NHC(CH3)2), 1.39 
(3H, s, NHC(CH3)), 0.97 (3H, d, J = 5.8, CH(CH3)2), 0.93 (3H, d, J = 6.0, CH(CH3)2); δC (100 MHz, CDCl3) 
176.0 (CO2H), 175.9 (CONH), 174.5 (CONH), 173.0 (CONH), 156.2 (CO2Bn), 136.2, 128.9, 128.8, 128.3 
(Ar), 67.6 (NHC(CH3)), 63.1 (PhCH2), 57.8 (NHC(CH3)2), 57.0 (NHC(CH3)2), 56.8 (NHC(CH3)2), 35.6 
(CH(CH3)2), 26.8 (NHC(CH3)2), 26.8 (NHC(CH3)2), 25.8 (NHC(CH3)2), 24.7 (NHC(CH3)2), 23.6 





(O-H, N-H), 2981m (C-H), 1660s (C=O), 1524m (C-N); m/z (ESI+) 521.3 ([M+H]+, 100%), HRMS (ESI+) 
found [M+Na]+ 543.2795 [C26H40N4O7Na]+ requires 543.2795; [α]D20 = +21.2 (c 1.00; CH3OH). 
Cbz-L-αMv-Aib3-Bip-OtBu – S31 
From S30 (505 mg, 0.97 mmol), EDC.HCl (278 mg, 
1.46 mmol), Et3N (0.26 mL, 1.46 mmol) and S24 (300 mg, 
0.97 mmol) according to General Procedure F. Crude S31 
was purified by flash column chromatography (99:1 
DCM:MeOH increasing to 19:1) to give the pure product as an off white powder. Rf 0.43 (19:1 
DCM:MeOH); m.p. 150-151 °C; δH (400 MHz, CDCl3) 7.66-7.08 (17H, m, NH, ArH), 6.13 (1H, d, J = 9.6, 
CONH), 5.22 (1H, d, J = 9.7, CONH), 5.15 (1H, d, J = 12.1, PhCH2), 4.99 (1H, d, J = 12.1, PhCH2), 3.20-
2.79 (4H, m, ArCH2), 1.89 (1H, sep, J = 6.7, CH(CH3)2), 1.75-1.18 (30H, m, NHC(CH3)2, NHC(CH3), 
C(CH3)3), 0.97 (3H, d, J = 6.4, CH(CH3)2), 0.95-0.89 (3H, m, CH(CH3)2); δC (100 MHz, CDCl3) 174.4 (CO-
NH), 173.6 (CONH), 173.5 (CONH), 172.4 (CONH), 171.6 (CO2C(CH3)3), 156.0 (CO2Bn), 141.3, 140.9, 
136.1, 135.5, 135.4, 130.8, 129.6, 129.5, 128.8, 128.7, 128.3, 127.9, 127.7, 127.5, 127.4, 127.2, 127.1, 126.4 
(Ar), 80.6 (C(CH3)3)a, 80.3 (C(CH3)3)b, 69.7 (ArCH2C)a, 69.4 (ArCH2C)b, 67.4 (NHC(CH3)), 63.0 (PhCH2), 
57.0 (NHC(CH3)2), 56.9 (NHC(CH3)2), 56.7 (NHC(CH3)2), 40.6 (ArCH2), 36.6 (ArCH2), 35.5 (CH(CH3)2), 
29.0 (C(CH3)3), 27.6 (NHC(CH3)2), 26.9 (NHC(CH3)2), 26.6 (NHC(CH3)2), 23.7 (NHC(CH3)2), 23.5 
(NHC(CH3)2), 23.2 (NHC(CH3)2), 22.7 (NHC(CH3)), 17.6 (CH(CH3)2), 17.4 (CH(CH3)2); νmax/cm-1 3322m 
(N-H), 2977m (C-H), 1665s (C=O), 1525m (C-N); m/z (ESI+) 834.4 ([M+Na]+, 100%), HRMS (ESI+) found 
[M+Na]+ 834.4425 [C46H61N5O8Na]+ requires 834.4412; [α]D20 = +10.0 (c 0.50; CH3OH). 
Cbz-L-αMv-Aib3-Bip-OH – S32 
From S31 (536 mg, 0.66 mmol) according to General 
Procedure D. Crude S32 was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give 
the pure product as white powder (480 mg, 0.63 mmol, 95%). 
Rf 0.17 (19:1 DCM:MeOH); m.p. 131-133 °C; δH (400 MHz, CD3OD) 7.45-7.10 (13H, m, ArH), 5.17 (1H, 
d, J = 12.7, PhCH2), 5.03 (1H, d, J = 12.7, PhCH2), 3.13-2.80 (4H, m, ArCH2), 1.98 (1H, sep, J = 6.5, 
CH(CH3)2), 1.62-1.48 (6H, m, NHC(CH3)2), 1.41-1.22 (9H, m, C(CH3)2), 1.18-1.01 (6H, m, NHC(CH3)2, 
NHC(CH3)), 0.99 (3H, d, J = 6.5, CH(CH3)2), 0.92 (3H, d, J = 6.5, CH(CH3)2); δC (125 MHz, CD3OD) 189.1 
(CO2H), 177.1 (CONH), 177.0 (CONH), 175.7 (CONH), 175.5 (CONH), 158.1 (CO2Bn), 142.2, 138.6, 
137.6, 130.6, 129.6, 129.0, 128.8, 128.8, 128.7, 128.5 (Ar), 70.8 (ArCH2C), 67.7 (NHC(CH3)), 63.9 (PhCH2), 
58.0 (NHC(CH3)2), 57.9 (NHC(CH3)2), 57.6 (NHC(CH3)2), 41.6 (ArCH2), 36.0 (CH(CH3)2), 27.5 





(NHC(CH3)2), 18.0 (CH(CH3)2), 17.9 (CH(CH3)2) 17.6 (NHC(CH3)); νmax/cm-1 3299m.br (O-H, N-H), 
2982m (C-H), 1703s (C=O), 1658m (C=O), 1528m (C-N); m/z (ESI−) 754.6 ([M-H]−, 100%), HRMS (ESI+) 
found [M+Na]+ 778.3784 [C42H53N5O8Na]+ requires 778.3792; [α]D20 = +20.0 (c 0.20; CH3OH). 
Cbz-L-αMv-Aib3-Bip-Aib2-OtBu – S33 
From S32 (461 mg, 0.61 mmol), EDC.HCl 
(175 mg, 0.92 mmol), Et3N (0.13 mL, 0.92 mmol) 
and S10 (164 mg, 0.67 mmol) according to 
General Procedure F. Crude S33 was purified 
by flash column chromatography twice (99:1 DCM:MeOH increasing to 19:1) to give the pure product as 
white powder (248 mg, 0.25 mmol, 41%). Rf 0.44 (19:1 DCM:MeOH); m.p. 224-226 °C; δH (400 MHz, 
CDCl3) 7.75 (1H, s, CONH), 7.67 (1H, s, CONH), 7.55 (1H, s, CONH), 7.45 (1H, s, CONH), 7.39 (1H, s, 
CONH),  7.37-7.27 (8H, m, ArH), 7.25-7.02 (5H, m, ArH), 6.18 (1H, d, CONH), 5.70 (1H, s, CONH), 5.16 
(1H, d, J = 12.2, PhCH2), 4.99 (1H, d, J = 12.2 PhCH2), 3.28 (1H, d, J = 13.9, ArCH2), 3.06 (1H, d, J = 13.9, 
ArCH2), 2.99 (1H, d, J = 13.6, ArCH2), 2.74 (1H, d, J = 13.6, ArCH2), 1.83 (1H, m, CH(CH3)2), 1.67 (3H, s, 
NHC(CH3)2), 1.58 (3H, s, NHC(CH3)2), 1.56 (6H, s, NHC(CH3)2), 1.48 (3H, s, NHC(CH3)2), 1.46 (3H, s, 
NHC(CH3)2), 1.42 (12H, s, NHC(CH3)2, C(CH3)3), 1.39 (3H, s, NHC(CH3)2), 1.35 (3H, s, NHC(CH3)), 
0.96-0.91 (6H, CH(CH3)2, NHC(CH3)2), 0.88 (3H, d, J = 6.4, CH(CH3)2), 0.77 (3H, s, NHC(CH3)2); 
δC (100 MHz, CDCl3) 174.6 (CONH), 174.3 (CONH), 173.7 (CONH), 173.5 (CONH), 173.3 (CONH), 
172.2 (CONH), 171.6 (CO2C(CH3)3), 156.0 (CO2Bn), 141.3, 141.0, 141.0, 140.6, 137.5, 137.1, 136.0, 135.6, 
135.5, 132.4, 132.3, 130.9, 129.6, 129.5, 128.9, 128.8, 128.4, 128.0, 127.7, 127.5, 127.5, 127.4, 127.2, 127.1, 
127.1, 126.6, 126.4 (Ar)a,b, 80.6 (C(CH3)3)a, 80.4 (C(CH3)3)b, 69.7 (ArCH2C)a, 69.5 (ArCH2C)b, 67.6 (PhCH2), 
63.0 (NHC(CH3)), 57.0 (NHC(CH3)2), 56.9 (NHC(CH3)2), 56.7 (NHC(CH3)2), 56.6 (NHC(CH3)2), 56.5 
(NHC(CH3)2), 40.6 (ArCH2), 36.7 (ArCH2)a, 36.2 (ArCH2)b, 35.7 (CH(CH3)2), 28.1 (C(CH3)3, NHC(CH3)2), 
27.6 (NHC(CH3)2), 27.0 (NHC(CH3)2), 26.7 (NHC(CH3)2), 23.7 (NHC(CH3)2), 23.5 (NHC(CH3)2), 23.2 
(NHC(CH3)2), 22.8 (NHC(CH3)2), 17.7 (NHC(CH3)), 17.4 (CH(CH3)2), 17.2 (CH(CH3)2); νmax/cm-1 3304s.br 
(N-H), 2981s (C-H), 1657s (C=O), 1528s (C-N), 1531m (C-N); m/z (ESI+) 491.0 ([M+2H]2+, 100%), HRMS 
(ESI+) found [M+Na]+ 1004.5445 [C54H75N7O10Na]+ requires 1004.5473; [α]D20 = +65.2 (c 1.00; CH3OH). 
 
Cbz-L-αMv-Aib3-Bip-Aib2-OH – S34 
From S33 (371 mg, 0.38 mmol) according to 
General Procedure D. Crude S34 was purified 





DCM:MeOH increasing to 19:1) to give the pure product as white powder (212 mg, 0.23 mmol, 61%). Rf 
0.16 (19:1 DCM:MeOH); m.p. 242-243 °C; δH (400 MHz, CDCl3) 7.95-7.73 (3H, m, CONH),  7.47-6.99 
(16H, m, ArH, CONH), 6.85 (1H, d, CONH), 6.34 (1H, s, CONH), 5.14 (1H, d, J = 12.4, PhCH2), 4.93 (1H, 
d, J = 12.4, PhCH2), 3.20 (1H, d, J = 13.2, ArCH2), 3.02 (1H, d, J = 13.7, ArCH2), 2.96 (1H, d, J = 13.2, 
ArCH2), 2.73 (1H, d, J = 13.7, ArCH2), 1.92 (1H, m, CH(CH3)2), 1.65 (3H, s, NHC(CH3)2), 1.63 (3H, s, 
NHC(CH3)2), 1.59 (6H, s, NHC(CH3)2), 1.54 (6H, s, NHC(CH3)2), 1.36 (3H, s, NHC(CH3)2), 1.33 (3H, s, 
NHC(CH3)2), 1.32 (3H, s, NHC(CH3)), 0.96 (3H, d, J = 6.0, CH(CH3)2), 0.93 (3H, s, NHC(CH3)2), 0.82 (3H, 
d, J = 6.0, CH(CH3)2), 0.71 (3H, s, NHC(CH3)2); δC (100 MHz, CDCl3) 180.4 (CO2H), 176.6 (CONH), 176.3 
(CONH), 176.0 (CONH), 175.0 (CONH), 174.1 (CONH), 173.9 (CONH), 156.5 (CO2Bn), 140.8, 140.7, 
137.0, 136.7, 134.8, 130.1, 129.5, 128.6, 128.2, 128.1, 127.9, 127.7, 127.6, 127.4, 127.2, 127.1 (Ar), 69.6 
(ArCH2C), 66.9 (PhCH2), 63.0 (NHC(CH3)), 57.3 (NHC(CH3)2), 56.9 (NHC(CH3)2), 56.8 (NHC(CH3)2), 56.7 
(NHC(CH3)2), 56.3 (NHC(CH3)2), 42.1 (ArCH2), 34.8 (ArCH2), 34.7 (CH(CH3)2), 27.5 (NHC(CH3)2), 27.4 
(NHC(CH3)2), 27.0 (NHC(CH3)2), 26.7 (NHC(CH3)2), 26.4 (NHC(CH3)2), 24.1 (NHC(CH3)2), 23.3 
(NHC(CH3)2), 22.8 (NHC(CH3)2), 22.6 (NHC(CH3)2), 21.7 (NHC(CH3)2), 17.3 (CH(CH3)2), 17.2 (CH(CH3)2) 
16.00 (NHC(CH3)); νmax/cm-1 3289w.br (O-H), 2982w (C-H), 1652s (C=O), 1527m (C-N); m/z (ESI+) 
949.6 ([M+Na]+, 100%), 927.6 ([M+H]+, 50%), HRMS (ESI+) found [M+Na]+ 948.4855 [C50H67N7O10Na]+ 
requires 948.4847; [α]D20 = +72.0 (c 0.50; CH3OH). 
Cbz-L-αMv-Aib3-Bip-Aib3-D-αMv-NHMe – 4b 
From S34 (100 mg, 0.11 mmol), 
EDC.HCl (32 mg, 0.17 mmol), 
Et3N (30 µL, 0.17 mmol) and 
D-S20 (26 mg, 0.11 mmol) 
according to General Procedure F. Crude 4b was purified by flash column chromatography twice (99:1 
DCM:MeOH increasing to 19:1) to give the pure product as white powder (76 mg, 0.07 mmol, 61%). Rf 
0.39 (19:1 DCM:MeOH); m.p. 240-242 °C; δH (500 MHz, CD2Cl2/CD3OD) 7.90-6.89 (18H, m, ArH, 
CONH), 5.16-4.90 (2H, m, PhCH2), 3.08-2.49 (7H, m, ArCH2, NHCH3), 2.18-1.73 (2H, m, CH(CH3)2), 1.56-
0.95 (42H, m, NHC(CH3)2, NHC(CH3)), 0.93-0.76 (12H, m, NHC(CH3)2); δC (125 MHz, CD2Cl2/CD3OD) 
177.0 (CONH), 176.9 (CONH), 176.7 (CONH), 176.6 (CONH), 176.4 (CONH), 176.2 (CONH), 175.5 
(CONH), 175.4 (CONH), 173.9 (CONH), 156.9 (CO2Bn), 141.4, 141.3, 137.2, 135.5, 130.6, 130.3, 129.2, 
128.9, 128.4, 128.3, 128.1, 127.9, 127.8 (Ar), 70.2 (ArCH2C), 67.6 (PhCH2), 63.5 (NHC(CH3)), 57.7-56.8 
(NHC(CH3)2), 36.8-34.7 (ArCH2), 30.3 (NHC(CH3)), 28.1-22.1 (NHCH3, NHC(CH3)2, NHC(CH3)), 19.3-16.3 
(CH(CH3)2); νmax/cm-1 3296s.br (N-H), 2982w (C-H), 1651s (C=O), 1527m (C-N); m/z (ESI+) 1159.7 
([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 1159.6530 [C61H88N10O11Na]+ requires 1159.6526; [α]D20 = 





N3-Aib-Bip-Aib-D-αMv-NHMe – S35 
From S26 (84 mg, 0.23 mmol), EDC.HCl (67 mg, 0.35 mmol), Et3N 
(60 µL, 0.35 mmol) and D-S20 (80 mg, 0.23 mmol) according to 
General Procedure F. Crude S35 was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure 
compound as a clear film (90 mg, 0.04 mmol, 57%). Rf 0.13 (97:3 DCM:MeOH); δH (400 MHz, CDCl3) 7.49-
7.37 (5H, m, ArH, CONH), 7.33 (2H, dd, J = 6.3, 6.3, ArH), 7.24-7.14 (3H, m, ArH, CONH), 6.90 (1H, s, 
CONH), 6.67 (1H, s, CONH), 3.32-3.09 (2H, m, ArCH2), 3.10 (2H, d, J = 11.0, ArCH2), 2.76 (3H, d, J = 3.2, 
NHCH3), 2.59 (1H, m, ArCH2), 2.14 (1H, m, CH(CH3)2), 1.57 (6H, s, N3C(CH3)2), 1.48 (6H, s, 
NHC(CH3)2), 1.43 (3H, s, NHC(CH3)), 0.90 (3H, d, J = 6.8, CH(CH3)2), 0.87 (3H, d, J = 6.8, CH(CH3)2); 
δC (100 MHz, CDCl3) 174.6 (CONH), 173.2 (CONH), 172.7 (CONH), 171.7 (CONH), 140.7, 140.5, 134.9, 
133.6, 130.1, 129.7, 128.6, 128.5, 128.1, 128.1, 128.0, 127.9 (Ar), 69.8 (ArCH2C), 64.3 (N3C(CH3)2), 63.4 
(NHC(CH3)), 57.5 (NHC(CH3)2), 35.4 (CH(CH3)2), 31.1 (ArCH2), 27.3 (NHC(CH3)2), 26.6 (NHCH3), 24.6 
(NHC(CH3)2), 24.5 (N3C(CH3)2), 24.0 (N3C(CH3)2), 17.9 (NHC(CH3)), 17.6 (CH(CH3)2), 17.2 (CH(CH3)2); 
νmax/cm-1 3346m.br (N-H), 2972w (C-H), 2113m (N3), 1664s (C=O), 1512m (C-N); m/z (ESI+) 576.3 
([M+H]+, 100%), HRMS (ESI+) found [M+Na]+ 598.3099 [C31H41N7O4]+ requires 598.3118; [α]D20 = −72.8 
(c 1.00; CH3OH).   
H-Aib-Bip-Aib-D-αMv-NHMe – S36 
From S35 (90 mg, 0.16 mmol) according to General Procedure B. 
S36 was obtained as a clear oil (88 mg, 0.16 mmol, quant.). Rf 0.06 
(19:1 DCM:MeOH); δH (400 MHz, CD3OD) 7.47-7.38 (4H, m, ArH), 
7.36-7.26 (2H, m, ArH), 7.23-7.08 (2H, m, ArH), 3.01-2.56 (7H, m, 
ArCH2, NHCH3), 2.20 (1H, m, CH(CH3)2), 1.56-1.42 (6H, m, H2NC(CH3)2, NHC(CH3)2), 1.41 (3H, s, 
H2NC(CH3)2), 1.40 (3H, s, NHC(CH3)), 1.39 (3H, s, NHC(CH3)), 1.02 (3H, d, J = 6.6, CH(CH3)2), 0.91 (3H, 
d, J = 6.6, CH(CH3)2); δC (100 MHz, CDCl3) 174.9 (CONH), 173.2 (CONH), 173.0 (CONH), 172.9 
(CONH), 140.3, 130.7, 128.5, 128.4, 128.3, 128.2, 128.0, 128.0, 127.9, 127.9, 127.8, 127.8 (Ar), 69.6 
(ArCH2C), 63.3 (NHC(CH3)), 57.3 (NHC(CH3)2), 55.1 (H2NC(CH3)2), 35.5 (CH(CH3)2), 29.8 (H2NC(CH3)2), 
29.2 (NHC(CH3)2), 26.7 (NHCH3), 18.6 (NHC(CH3)), 17.7 (CH(CH3)2), 17.6 (CH(CH3)2); νmax/cm-1 
3328m.br (N-H), 2971w (C-H), 1667s (C=O), 1512m (C-N); m/z (ESI+) 550.4 ([M+H]+, 100%), HRMS 
(ESI+) found [M+Na]+ 572.3200 [C31H43N5O4Na]+ requires 572.3213; [α]D20 = −58.4 (c 1.00; CH3OH). 
Cbz-L-αMv-Aib4-OH – S37 






Cbz-L-αMv-Aib5-Bip-Aib-D-αMv-NHMe – 4c 
From S37 (97 mg, 0.16 mmol), 
EDC.HCl (46 mg, 0.24 mmol), 
Et3N (40 µL, 0.24 mmol) and S36 
(88 mg, 0.16 mmol) according to 
General Procedure F. Crude 4c was purified by flash column chromatography (99:1 DCM:MeOH 
increasing to 19:1) to give the pure compound as a white solid (34 mg, 0.03 mmol, 19%). Rf 0.32 (19:1 
DCM:MeOH); m.p. 190-192 °C; δH (500 MHz, CDCl3) 7.77-6.89 (21H, m, ArH, CONH), 6.68 (1H, s, 
CONH), 5.86 (1H, s, CONH), 5.13-4.93 (2H, m, PhCH2), 3.26-2.51 (7H, m, ArCH2, NHCH3), 2.34-1.88 
(2H, m, CH(CH3)2), 1.81-1.09 (42H, m, NHC(CH3)2, NHC(CH3)), 0.95-0.81 (12H, m, NHC(CH3)2); 
δC (125 MHz, CD2Cl2/CD3OD) 176.0 (CONH), 175.8 (CONH), 175.8 (CONH), 175.6 (CONH), 175.1 
(CONH), 174.8 (CONH), 174.3 (CONH), 173.4 (CONH), 156.3 (CO2Bn), 140.7, 140.7, 136.5, 130.2, 129.8, 
128.6, 128.3, 127.8, 127.3, 127.3 (Ar), 69.7 (ArCH2C), 67.0 (PhCH2), 63.2 (NHC(CH3)), 62.9 (NHC(CH3)), 
57.3-56.2 (NHC(CH3)2), 36.0-33.7 (ArCH2), 31.9 (NHC(CH3)), 29.8-21.7 (NHCH3, NHC(CH3)2, NHC(CH3)), 
18.3-16.6 (CH(CH3)2); νmax/cm-1 3294m.br (N-H), 2983m (C-H), 1652s (C=O), 1530m (C-N); m/z (ESI+) 
1159.7 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 1159.6530 [C61H88N10O11Na]+ requires 1159.6526; 
[α]D20 = −7.4 (c 0.50; CH3OH). 
H-Aib3-OtBu – S38 
Prepared as previously reported.5 
 
Cbz-Gly-Aib3-OtBu – S39 
From Cbz-Gly-OH (211 mg, 1.01 mmol), NMM (0.29 mL, 
1.58 mmol), iBuCOCl (0.13 mL, 1.01 mmol) and S38 (500 mg, 
1.52 mmol) according to General Procedure E. Crude S39 was 
purified by flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure product as 
a white powder (467 mg, 0.90 mmol, 89%). Rf 0.31 (19:1 DCM:MeOH); m.p. 139-141 °C; δH (500 MHz, 
CDCl3) 7.38-7.30 (5H, m, PhH) 7.05 (1H, s, CONH), 6.80 (1H, s, CONH), 6.54 (1H, s, CONH), 5.72 1H, s, 
br, NHCO2), 5.13 (2H, s, PHCH2), 3.77 (2H, d, J = 5.1, NHCH2), 1.48 (6H, s, NHC(CH3)2), 1.46 (6H, s, 
NHC(CH3)2), 1.45 (6H, s, NHC(CH3)2), 1.43 (9H, s, C(CH3)3); δC (125 MHz, CDCl3) 174.0 (CONH), 173.3 





(C(CH3)3), 67.5 (PhCH2), 57.2 (NHC(CH3)2), 56.8 (NHC(CH3)2), 53.5 (NHC(CH3)2), 45.5 (NHCH2), 27.9 
(C(CH3)3), 25.2 (NHC(CH3)2), 25.1 (NHC(CH3)2), 24.5 (NHC(CH3)2); νmax/cm-1 3323m.br (N-H), 2982m 
(C-H), 1672s (C=O), 1531s (C-N); m/z (ESI+) 543.7 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 
543.2800 [C26H40N4O7Na]+ requires 543.2789. 
Cbz-Gly-Aib3-OH – S40 
From S39 (467 mg, 0.90 mmol) according to General Procedure D. 
Crude S40 was purified by flash column chromatography (99:1 
DCM:MeOH increasing to 19:1) to give the pure product as a white 
powder (361 mg, 0.78 mmol, 87%). Rf 0.30 (19:1 DCM:MeOH); m.p. 193-195 °C; δH (400 MHz, CD3OD) 
8.31 (1H, s, br, CONH), 7.56 (1H, s, br, CONH), 7.42 (1H, s, br, CONH), 7.35-7.24 (5H, m, PhH) 5.07 
(2H, s, PHCH2), 3.68 (2H, d, J = 5.1, NHCH2), 1.44 (6H, s, NHC(CH3)2), 1.40 (6H, s, NHC(CH3)2), 1.38 
(6H, s, NHC(CH3)2); δC (100 MHz, CD3OD) 178.2 (CO2H), 176.4 (CONH), 175.9 (CONH), 172.3 (CONH), 
159.3 (CO2Bn), 138.1, 129.5, 129.1, 128.9 (Ar), 68.0 (PhCH2), 57.8 (NHC(CH3)2), 57.7 (NHC(CH3)2), 56.9 
(NHC(CH3)2), 45.2 (NHCH2), 25.4 (C(CH3)3), 25.2 (NHC(CH3)2); νmax/cm-1 2986m (C-H), 2481m.br (O-H), 
1652s (C=O), 1429s (C-N); m/z (ESI+) 487.4 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 487.2160 
[C26H40N4O7Na]+ requires 487.2163. 
Cbz-Gly-Aib4-L/D-αMv-NHMe – S41 
From S40 (180 mg, 0.54 mmol), EDC.HCl (156 mg, 
0.82 mmol), DIPEA (0.14 mL, 0.82 mmol) and S20 
(124 mg, 0.54 mmol) according to General 
Procedure F. Crude S41 was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) 
to give the pure product as a white powder (137 mg, 
0.25 mmol, 46%). Rf 0.09 (19:1 DCM:MeOH); m.p. 242-244 °C; δH (400 MHz, CDCl3) 8.36 (1H, s, 
CONH), 7.99 (1H, s, CONH), 7.77 (1H, s, CONH), 7.72 (1H, s, CONH),  7.40-7.25 (6H, m, PhH, CONH), 
5.14 (1H, d, J = 12.5, PHCH2), 5.08 (1H, d, J = 12.5, PHCH2), 3.80 (1H, d, J = 16.6, NHCH2), 3.67 (1H, d, J = 
16.6, NHCH2), 2.74 (3H, s, NHCH3), 2.13 (1H, sep, J = 6.8, CH(CH3)2), 1.46 (3H, s, NHC(CH3)2), 1.43 (3H, 
s, NHC(CH3)2), 1.42 (3H, s, NHC(CH3)2), 1.41 (3H, s, NHC(CH3)2), 1.40 (3H, s, NHC(CH3)2), 1.39 (3H, s, 
NHC(CH3)2), 1.38 (3H, s, NHC(CH3)), 1.01 (3H, d, J = 6.8, CH(CH3)2), 0.93 (3H, d, J = 6.8, CH(CH3)2); 
δC (125 MHz, CD3OD) 150.5 (CONHCH3), 179.9 (CONH), 179.5 (CONH), 179.4 (CONH), 179.2 (CONH), 
174.7 (CH2CONH), 161.9z (CO2Bn), 140.7, 132.1, 131.7, 131.3 (Ar), 70.3 (NHC(CH3)), 67.0 (PhCH2), 60.7 
(NHC(CH3)2), 60.4 (NHC(CH3)2), 60.3 (NHC(CH3)2), 60.1 (NHC(CH3)2), 47.8 (NHCH2), 39.4 (CH(CH3)2), 





(NHC(CH3)2), 26.7 (NHC(CH3)2), 26.5 (NHC(CH3)2), 26.4 (NHC(CH3)2), 26.3 (NHC(CH3)), 20.9 
(CH(CH3)2, 20.3 (CH(CH3)2); νmax/cm-1 2983m (C-H), 2472m.br (N-H), 1646s (C=O), 1413m (C-N); m/z 
(ESI+) 699.6 ([M+Na]+, 100%), HRMS (ESI+) found [M+H]+ 676.4019 [C33H54N7O8]+ requires 676.4028; (L) 
[α]D20 = +30.8 (c 1.00; CH3OH), (D) [α]D20 = −26.3 (c 0.99, CH3OH). 
H-Gly-Aib4-L/D-αMv-NHMe – S42 
From S41 (137 mg, 0.21 mmol) according to General 
Procedure B. S42 was obtained as a white powder 
(105 mg, 0.19 mmol, 92%). Rf 0.00 (19:1 DCM:MeOH); 
m.p. 258-260 °C; δH (400 MHz, CD3OD) 3.37-3.31 (2H, 
m, NHCH2), 2.77 (3H, s, NHCH3), 2.16 (1H, sep, J = 6.7, 
CH(CH3)2), 1.51-1.42 (24H, m, NHC(CH3)2), 1.39 (3H, s, NHC(CH3)), 1.04 (3H, d, J = 6.7, CH(CH3)2), 0.96 
(3H, d, J = 6.7, CH(CH3)2); δC (100 MHz, CD3OD) 177.9 (CONHCH3), 177.3 (CONH), 176.9 (CONH), 
176.7 (CONH), 176.5 (CONH), 174.5 (CH2CONH) 64.5 (NHC(CH3)), 60.7 (NHC(CH3)2), 58.1 
(NHC(CH3)2), 57.8 (NHC(CH3)2), 57.7 (NHC(CH3)2), 57.4 (NHC(CH3)2), 45.0 (NHCH2), 36.9 
(NHCH(CH3)2), 27.4 (NHC(CH3)3), 26.9 (NHC(CH3)2), 26.6 (NHC(CH3)2), 26.5 (NHCH3), 26.2 (NHC(CH3)-
2) 24.4 (NHC(CH3)2), 24.0 (NHC(CH3)2), 23.8 (NHC(CH3)2), 23.8 (NHC(CH3)2), 23.8 (NHC(CH3)), 18.3 
(CH(CH3)2, 17.7 (CH(CH3)2); νmax/cm-1 3378m.br (N-H), 2970m (C-H), 2476m.br (N-H), 1639s (C=O), 
1424s (C-N); m/z (ESI+) 564.4 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 564.3480 [C25H47N7O6Na]+ 
requires 564.3480; (L) [α]D20 = +19.6 (c 1.00; CH3OH), (D) [α]D20 = −22.4 (c 1.00; CH3OH). 
Cbz-L-αMv-Aib4-Gly-Aib4-L-αMv-NHMe – 5a 
From S37 (56 mg, 
0.09 mmol), 
EDC.HCl (26 mg, 
0.14 mmol), DIPEA (24 µL, 0.14 mmol) and L-S42 (46 mg, 0.09 mmol) according to General Procedure 
F. Crude 5a was purified by flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give 
the pure compound as a clear solid (26 mg, 0.02 mmol, 26%). Rf 0.15 (19:1 DCM:MeOH); m.p. 245-247 °C 
δH (400 MHz, CDCl3) 8.19 (1H, t, J = 5.4, CONH), 7.91 (1H, s, CONH), 7.81 (1H, s, CONH), 7.78 (1H, s, 
CONH), 7.69 (1H, s, CONH), 7.61 (H, s, CONH), 7.51 (1H, s, CONH), 7.46-7.30 (7H, m, CONH, PhH), 
7.02 (1H, s, CONH), 6.64 (1H, s, br, CONH), 5.68 (1H, s, br, CONH), 5.09 (2H, ABq, ΔδAB = 0.03, JAB = 
12.4, PhCH2), 3.86 (1H, dd, J = 16.4, 5.0, NHCH2), 3.67 (1H, dd, J = 16.4, 6.1, NHCH2), 2.79 (3H, d, J = 4.5, 
NHCH3), 2.13 (1H, sep, J = 6.7, CH(CH3)2), 1.99 (1H, m, CH(CH3)2), 1.48 (3H, s, NHC(CH3)2), 1.45 (12H, 
s, NHC(CH3)2), 1.44 (9H, s, NHC(CH3)2), 1.42 (6H, s, NHC(CH3)2), 1.41 (9H, s, NHC(CH3)2), 1.39 (6H, s, 





m, CH(CH3)2); δC (100 MHz, CDCl3) 177.9, 176.6, 176.3, 176.1, 175.8, 175.6, 175.2, 174.9, 174.6, 173.5, 
171.0 (CONH), 156.5 (CO2Bn), 136.3, 128.9, 128.8, 128.3 (Ar), 67.6 (PhCH2), 63.4 (NHC(CH3)), 63.3 
(NHC(CH3)), 57.1, 57.0, 56.9, 56.9, 56.7 (NHC(CH3)2), 45.5 (NHCH2), 36.0, 35.6 (CH(CH3)2), 27.6 
(NHCH3), 27.5-26.9 (NHC(CH3)2), 23.0-22.8 (NHC(CH3)2, NHC(CH3)), 17.9, 17.4, 17.3, 17.2 (CH(CH3)2); 
νmax/cm-1 3289m (N-H), 2984w (C-H), 1655s (C=O), 1535m (C-N); m/z (ESI+) 1152.8 ([M+Na]+, 100%), 
HRMS (ESI+) found [M+H]+ 1129.6974 [C55H93N12O13]+ requires 1129.6980; [α]D20 = +44.2 (c 0.95; 
CH3OH). 
Cbz-L-αMv-Aib4-Gly-Aib4-D-αMv-NHMe – 5b 
From S37 (62 mg, 
0.10 mmol), 
EDC.HCl (28 mg, 
0.15 mmol), DIPEA (26 µL, 0.15 mmol) and D-S42 (53 mg, 0.09 mmol) according to General Procedure 
F. Crude 5b was purified by flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give 
the pure compound as a clear solid (26 mg, 0.02 mmol, 26%). Rf 0.18 (19:1 DCM:MeOH); m.p. 240-242 °C 
δH (400 MHz, CDCl3) 8.06 (1H, s, br, CONH), 7.95 (1H, s, CONH), 7.76 (1H, s, CONH), 7.75 (1H, s, 
CONH), 7.62 (1H, s, CONH), 7.52 (2H, s, CONH), 7.40-7.29 (6H, m, CONH, PhH), 7.22 (1H, s, CONH), 
7.10 (1H, s, CONH), 6.94 (1H, s, br, CONH), 6.09 (1H, s, br, CONH), 5.13 (1H, d, J = 12.4, PhCH2), 5.06 
(1H, d, J = 12.4, PhCH2), 3.95 (1H, dd, J = 16.5, 6.2, NHCH2), 3.66 (1H, dd, J = 16.5, 4.9, NHCH2), 2.77 
(3H, d, J = 4.2, NHCH3), 2.25 (1H, sep, J = 6.3, CH(CH3)2), 2.15 (1H, sep, J = 6.3, CH(CH3)2), 1.55 (3H, s, 
NHC(CH3)2), 1.53 (6H, s, NHC(CH3)2), 1.52 (3H, s, NHC(CH3)2), 1.49 (15H, s, NHC(CH3)2), 1.47 (6H, s, 
NHC(CH3)2), 1.45 (6H, s, NHC(CH3)2), 1.42 (3H, s, NHC(CH3)2), 1.41 (3H, s, NHC(CH3)2), 1.40 (3H, s, 
NHC(CH3)2), 1.39 (3H, s, NHC(CH3)), 1.33 (3H, s, NHC(CH3)), 1.02-0.90 (12H, m, CH(CH3)2); 
δC (100 MHz, CDCl3) 177.3, 176.8, 176.4, 176.1, 175.9, 175.5, 175.1, 174.9, 174.8, 174.3, 171.1 (CONH), 
156.5 (CO2Bn), 136.4, 128.8, 128.6, 128.0 (Ar), 67.3 (PhCH2), 63.1 (NHC(CH3)), 62.9 (NHC(CH3)), 57.2, 
57.0, 57.0, 56.9, 56.8 (NHC(CH3)2), 45.1 (NHCH2), 35.1, 34.6 (CH(CH3)2), 26.8-24.0 (NHCH3, NHC(CH3)2, 
NHC(CH3)), 18.0, 17.8, 17.5, 17.4 (CH(CH3)2); νmax/cm-1 3290m (N-H), 2984w (C-H), 1651s (C=O), 
1529m (C-N); m/z (ESI+) 1152.8 ([M+Na]+, 100%), HRMS (ESI+) found [M+H]+ 1129.6980 [C55H93N12O13]+ 
requires 1129.6980; [α]D20 = −7.5 (c 0.40, CH3OH).   
Cbz-L-αMv-Aib2-OH – S43 
From S11 (195 mg, 0.39 mmol) according to General Procedure D. Crude 
S43 was purified by automatic purification system (99:1 DCM:MeOH 
increasing to 9:1) to give the pure product (121 mg, 0.28 mmol, 72%). Rf 0.21 





6.46 (1H, s, CONH), 5.35 (1H, s, CONH), 5.16 (1H, d, J = 12.2, PhCH2), 5.03 (1H, d, J = 12.2, PhCH2), 1.96 
(1H, sep, J = 6.9, CH(CH3)2), 1.55 (3H, s, NHC(CH3)2), 1.52 (3H, s, NHC(CH3)2), 1.48 (3H, s, NHC(CH3)2), 
1.41 (3H, s, NHC(CH3)2), 1.26 (3H, s, NHC(CH3)), 0.97 (3H, d, J = 6.9, CH(CH3)2), 0.92 (3H, d, J = 6.9, 
CH(CH3)2); δC (100 MHz, CDCl3); 174.9 (CO2H), 173.1 (CONH), 	169.3 (CONH), 156.2 (CO2Bn), 136.1, 
128.9, 128.8, 128.4 (Ar), 67.6 (PhCH2), 63.3 (NHC(CH3)), 57.5 (NHC(CH3)2),	 57.0 (NHC(CH3)2), 35.7 
(CH(CH3)2), 26.9 (CH(CH3)2), 25.4 (NHCH3), 24.8 (NHC(CH3)2), 23.8 (NHC(CH3)2), 17.5 (NHC(CH3)), 17.4 
(CH(CH3)2), 17.2 (CH(CH3)2); νmax/cm-1 3350m.br (N-H, O-H), 2924m (C-H), 1705s (C=O), 1667s (C=O), 
1510s (C-N), 1453m (C-O); m/z (ESI+) 458.2 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 458.2260 
[C22H33N3O6Na]+ requires 458.2262; [α]D20 = +12.0 (c 1.00; CH3OH). 
N3-Aib3-OH – S44 
Prepared as previously reported.8 
 
N3-Aib4-D-αMv-NHMe – S45 
From S44 (249 mg, 0.83 mmol), EDC.HCl (287 mg, 1.50 mmol), 
Et3N (0.21 mL, 1.50 mmol) and D-S20 (229 mg, 1.00 mmol) 
according to General Procedure F. Crude S45 was purified by 
automatic purification system (99:1 DCM:MeOH increasing to 9:1) to give the pure product (260 mg, 
0.51 mmol, 61%). Rf 0.21 (19:1 DCM:MeOH); m.p. 209-210 °C; δH (500 MHz, CDCl3) 7.52 (1H, s, CONH) 
7.25 (1H, d, J = 4.6, NHCH3), 7.03 (1H, s, CONH), 6.89 (1H, s, CONH), 6.24 (1H, s, CONH), 2.77 (3H, d, J 
= 4.6, NHCH3), 2.12 (1H, sep, J = 6.9, CH(CH3)2), 1.54 (3H, s, NHC(CH3)2), 1.52 (3H, s, NHC(CH3)2), 1.48 
(3H, s, NHC(CH3)2), 1.48 (3H, s, NHC(CH3)2), 1.47 (3H, s, NHC(CH3)2), 1.46 (3H, s, NHC(CH3)2), 1.45 
(3H, s, N3C(CH3)2), 1.44 (3H, s, N3C(CH3)2), 1.36 (3H, s, NHC(CH3)), 0.97 (3H, d, J = 6.9, CH(CH3)2), 0.94 
(3H, d, J = 6.9, CH(CH3)2); δC (125 MHz, CDCl3); 175.1 (CONH), 174.2 (CONH), 	174.1 (CONH), 	173.2 
(CONH), 	172.8 (CONH), 	64.1 (NHC(CH3)), 63.4 (N3C(CH3)2), 57.3 (NHC(CH3)2),	57.1 (NHC(CH3)2), 56.8 
(NHC(CH3)2), 35.8 (CH(CH3)2), 27.3 (NHCH3), 27.2 (N3C(CH3)2), 26.5 (NHC(CH3)2), 26.2 (NHC(CH3)2), 
24.5 (NHC(CH3)2), 24.3 (N3C(CH3)2), 23.7 (NHC(CH3)2), 23.5 (NHC(CH3)2), 23.4 (NHC(CH3)2), 17.9 
(NHC(CH3)), 17.7 (CH(CH3)2), 17.2 (CH(CH3)2); νmax/cm-1 3325m.br (N-H), 2982w (C-H), 2113m (N3), 
1661s (C=O), 1526m (C-N); m/z (ESI+) 533.3 ([M+Na]+, 100%), HRMS (ESI+) found [M+H]+ 511.3345 
[C23H43N8O5]+ requires 511.3351; [α]D20 = −24.0 (c 1.00; CH3OH). 





From S45 (260 mg, 0.51 mmol) according to General 
Procedure B. S46 was obtained as a white solid (247 mg, 
0.51 mmol, quant.). Rf 0.05 (19:1 DCM:MeOH); m.p. 185-
186 °C; δH (400 MHz, CD3OD) 2.76 (3H, d, J = 4.1, NHCH3), 2.16 (1H, sep, J = 6.8, CH(CH3)2), 1.49 (3H, 
s, H2NC(CH3)2), 1.46 (3H, s, H2NC(CH3)2), 1.45 (3H, s, NHC(CH3)2), 1.45 (3H, s, NHC(CH3)2), 1.44 (3H, 
s, NHC(CH3)2), 1.42 (3H, s, NHC(CH3)2), 1.38 (3H, s, NHC(CH3)2), 1.37 (6H, s, NHC(CH3)2), NHC(CH3)), 
1.04 (3H, d, J = 6.8, CH(CH3)2), 0.96 (3H, d, J = 6.8, CH(CH3)2); δC (100 MHz, CD3OD); 179.3 (CONH), 
177.3 (CONH), 	177.0 (CONH), 	177.0 (CONH), 	176.1 (CONH), 	64.5 (NHC(CH3)), 58.3 (NHC(CH3)2),	
58.1 (NHC(CH3)2), 57.5 (NHC(CH3)2), 55.9 (H2NC(CH3)2), 36.9 (CH(CH3)2), 28.3 (H2C(CH3)2), 27.8 
(H2C(CH3)2), 27.4 (NHCH3), 27.0 (NHC(CH3)2), 26.5 (NHC(CH3)2), 26.0 (NHC(CH3)2), 24.0 (NHC(CH3)2), 
23.8 (NHC(CH3)2), 23.7 (NHC(CH3)2), 18.4 (NHC(CH3)), 17.7 (CH(CH3)2), 17.4 (CH(CH3)2); νmax/cm-1  
3315m.br (N-H), 2982w (C-H), 1655s (C=O), 1526m (C-N); m/z (ESI+) 485.3 ([M+H]+, 100%), 507.3 
([M+Na]+, 60%), HRMS (ESI+) found [M+Na]+ 507.3269 [C23H44N6O5Na]+ requires 507.3269; [α]D20 = 
−19.0 (c 1.00; CH3OH). 
(S)-2-amino-2-methylpropanoic-3-13C acid hydrobromide – S47 
 Prepared as previously reported.9 
 
(S)-2-azido-2-methylpropanoic-3-13C acid – S48 
According to the procedure of Lee:10 To a stirred solution of NaN3 (2.05 g, 31.5 mmol) in 
water (5.25 mL) and DCM (8.75 mL) at 0 °C was added trifluoromethanesulfonic anhydride 
over 5 min. The reaction was stirred for a further 2 h. The reaction mixture was separated, and the 
aqueous further extracted with DCM (2 × 4.7 mL). The combined organic layers were washed with sat. aq. 
NaHCO3 (15 mL). The resultant solution of trifluoromethanesulfonyl azide in DCM was never allowed to 
evaporate to dryness, but added as soon as possible to a stirred solution of S47 (580 mg, 3.13 mmol), 
K2CO3 (1.09 g, 7.89 mmol) and CuSO4 (80 mg, 0.32 mmol) in water (10.5 mL) and MeOH (20.5 mL). The 
reaction was stirred overnight then diluted with water (60 mL), acidified to pH 6 with conc. HCl and 
further diluted with phosphate buffer (250 mM, pH 6.2, 120 mL). This was then washed with EtOAc (4 × 
50 mL). The aqueous was acidified to pH 1 with further conc. HCl and extracted with EtOAc (3 × 50 mL). 
The organic solvent was removed in vacuo to give S48 as a yellow oil (241 mg, 1.85 mmol, 59%). Rf 0.29 
(19:1 DCM:MeOH); δH (500 MHz, CDCl3) 11.09 (1H, s, br, CO2H), 1.53 (3H, d, J = 129.9, 
NHC(CH3)(13CH3)), 1.53 (3H, d, J = 4.4, NHC(CH3)(13CH3); δC (125 MHz, CDCl3) 179.2 (CO2H), 63.0 (d, J 





(C=O), 1470m (C-O); m/z (ESI−) 129.0 ([M-H]−, 100%), HRMS (ESI−) found [M-H]− 129.0498 
[C313CH6N3O2]+ requires 129.0499. 
N3-Aib*-Aib4-D-αMv-NHMe – S49 
From S48 (30 mg, 0.23 mmol), oxalyl chloride (30 µL, 
0.35 mmol), S46 (186 mg, 0.38 mmol) and Et3N (45 µL, 
0.38 mmol) according to General Procedure A. Crude 
S49 was purified by flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure 
compound as a white solid (75 mg, 0.13 mmol, 57%). Rf 0.19 (19:1 DCM:MeOH); m.p. 250-251 °C; 
δH (400 MHz, CDCl3) 7.62 (1H, s, CONH), 7.40 (1H, s, CONH), 7.32 (1H, d, J = 5.0, NHCH3), 7.03 (1H, s, 
CONH), 6.93 (1H, s, CONH), 6.31 (1H, s, CONH), 2.79 (3H, d, J = 4.7, NHCH3), 2.15 (1H, sep, J = 6.6, 
CH(CH3)2), 1.72-1.36 (6H, m, N3C(CH3)(13CH3), 1.56-1.52 (3H, m, NHC(CH3)2), 1.50 (3H, s, NHC(CH3)2), 
1.49 (3H, s, NHC(CH3)2), 1.48 (3H, s, NHC(CH3)2), 1.47 (3H, s, NHC(CH3)2), 1.47 (3H, s, NHC(CH3)2), 
1.45 (3H, s, NHC(CH3)2), 1.44 (6H, s, NHC(CH3)2, NHC(CH3)), 0.99 (3H, d, J = 6.6, CH(CH3)2), 0.95 (3H, 
d, J = 6.6, CH(CH3)2); δC (100 MHz, CDCl3) 175.3 (CONH), 175.3 (CONH), 174.3 (CONH), 173.5 
(CONH), 173.3 (CONH), 173.2 (CONH), 64.1 (d, J = 36.8, N3C(CH3)(13CH3)), 63.4 (NHC(CH3)), 57.2 
(NHC(CH3)2), 57.0 (NHC(CH3)2), 57.0 (NHC(CH3)2), 56.9 (NHC(CH3)2), 35.8 (CH(CH3)2), 27.4 
(NHC(CH3)2), 27.2 (NHCH3), 26.8 (NHC(CH3)2), 26.5 (NHC(CH3)2), 26.1 (NHC(CH3)2), 24.5 
(N3C(13CH3)(CH3)minor), 24.4 (N3C(CH3)(13CH3)major), 23.8 (NHC(CH3)2), 23.6 (NHC(CH3)2), 23.5 
(NHC(CH3)2), 17.8 (NHC(CH3)), 17.8 (CH(CH3)2), 17.3 (CH(CH3)2);	 νmax/cm-1 3317m.br (N-H), 2984w 
(C-H), 2113m (N3), 1656s (C=O), 1521m (C-N); m/z (ESI+) 619.4 ([M+Na]+, 100%), HRMS (ESI+) found 
[M+Na]+ 619.3732 [C261H49N9O6Na]+ requires 619.3732; [α]D20 = −4.0 (c 1.00; CH3OH). 
H-Aib*-Aib4-D-αMv-NHMe – S50 
From S49 (75 mg, 0.13 mmol) according to General 
Procedure B. S50 was obtained as a white solid (58 mg, 
0.10 mg, 77%). Rf 0.12 (19:1 DCM:MeOH); m.p. 229-
230 °C; δH (400 MHz, CD3OD) 2.74 (3H, s, NHCH3), 2.13 (1H, sep, J = 6.7, CH(CH3)2), 1.66-1.30 (3H, m, 
H2NC(CH3)(13CH3), 1.48 (3H, s, H2NC(CH3)(13CH3), 1.46 (12H, s, NHC(CH3)2), 1.44 (3H, s, NHC(CH3)2), 
1.42 (3H, s, NHC(CH3)2), 1.42 (3H, s, NHC(CH3)2), 1.40 (3H, s, NHC(CH3)2), 1.40 (3H, s, NHC(CH3)), 
1.01 (3H, d, J = 6.7, CH(CH3)2), 0.94 (3H, d, J = 6.7, CH(CH3)2); δC (100 MHz, CD3OD) 177.8 (CONH), 
177.3 (CONH), 177.3 (CONH), 177.0 (CONH), 176.5 (CONH), 176.3 (CONH), 64.6 (NHC(CH3)), 58.1 
(NHC(CH3)2), 58.0 (H2NC(13CH3)(CH3)),  57.8 (NHC(CH3)2), 57.8 (NHC(CH3)2), 57.8 (NHC(CH3)2), 36.9 
(CH(CH3)2), 27.4 (NHC(CH3)2),  27.2 (NHCH3), 27.0 (NHC(CH3)2), 26.6 (H2NC(CH3)(13CH3)major), 26.4 





23.8 (NHC(CH3)2), 23.3 (NHC(CH3)2), 18.3 (NHC(CH3)), 17.7 (CH(CH3)2), 17.5 (CH(CH3)2);	 νmax/cm-1 
3314m.br (N-H), 2982w (C-H), 1653s (C=O), 1526m (C-N); m/z (ESI+) 593.4 ([M+Na]+, 100%), HRMS 
(ESI+) found [M+Na]+ 593.3824 [C2613CH51N7O6Na]+ requires 593.3827; [α]D20 = −32.0 (c 1.00; CH3OH). 
Cbz-L-αMv-Aib2-Aib*-Aib4-D-αMv-NHMe – 6a 
From S43 (53 mg, 0.12 mmol), 
EDC.HCl (35 mg, 0.18 mmol), Et3N 
(26 µL, 0.18 mmol) and S50 
(58 mg, 0.10 mmol) according to General Procedure F. Crude 6a was purified by automatic purification 
system (99:1 DCM:MeOH increasing to 9:1) to give the pure product as a white solid (54 mg, 0.05 mmol, 
50%). Rf 0.18 (19:1 DCM:MeOH); m.p. >250 °C;	δH (500 MHz, CDCl3) 7.75 (1H, s, CONH) 7.72 (1H, s, 
CONH), 7.69 (1H, s, CONH), 7.66 (1H, s, CONH), 7.62 (1H, s, CONH), 7.49 (1H, s, CONH), 7.39-7.30 
(6H, m, PhH, CONH), 7.08 (1H, s, CONH), 6.71 (1H, s, CONH), 5.86 (1H, s, CONH), 5.09 (2H, ABq, ΔδAB 
= 0.04, JAB = 11.7, PhCH2), 2.78 (3H, d, J = 4.6, NHCH3), 2.33 (1H, m, CH(CH3)2), 2.17 (1H, m. CH(CH3)2), 
1.51 (9H, s, NHC(CH3)2), 1.48 (9H, s, NHC(CH3)2), 1.48 (6H, s, NHC(CH3)2), 1.46 (7H, s, NHC(CH3)2, 
NHC(13CH3) (CH3)minor), 1.46 (2H, d, J = 125.4, NHC(CH3)(13CH3)major), 1.43 (3H, s, NHC(CH3)2), 1.42 (3H, 
s, NHC(CH3)2), 1.41 (2H, s, NHC(CH3)(13CH3)major), 1.41 (1H, d, J = 125.4, NHC(13CH3)(CH3)minor), 1.41 
(3H, s, NHC(CH3), 1.34 (3H, s, NH(CH3)), 1.00-0.91 (12H, m, CH(CH3)2); δC (125 MHz, CDCl3); 176.3 
(CONH), 175.9 (CONH), 175.8 (CONH), 	175.8 (CONH), 	175.6 (CONH), 	175.5 (CONH), 	174.7 (CONH), 	
174.5 (CONH), 	 173.8 (CONH), 	 156.3 (CO2Bn), 136.1, 128.9, 128.7, 128.2 (Ar), 67.5 (PhCH2), 63.1 
(NHC(CH3)), 62.8 (NHC(CH3)), 57.3 (NHC(CH3)2),	 56.9 (NHC(CH3)2), 56.9 (NHC(CH3)2), 56.9 
(NHC(CH3)2), 56.8 (NHC(CH3)2), 56.7 (NHC(CH3)2), 56.6 (NHC(CH3)2), 34.8-34.6 (CH(CH3)2), 26.9 
(NHC(CH3)2), 26.5 (NHCH3), 26.2 (NHC(CH3)2), 25.8-24.1 (NHC(CH3)2), NHC(13CH3)), 18.4 (NHC(CH3)), 
18.0 (NHC(CH3)), 17.9 (CH(CH3)2), 17.8 (CH(CH3)2), 17.7 (CH(CH3)2), 17.5 (CH(CH3)2); νmax/cm-1 
3293m.br (N-H), 2981w (C-H), 1656s (C=O). 1534m (C-N); m/z (ESI+) 1010.6 ([M+Na]+, 100%), HRMS 
(ESI+) found [M+Na]+ 1010.6070 [C4813CH82N10O11Na]+ requires 1010.6090; [α]D21.5 = −0.2 (c 0.25; 
CH3OH). 
N3-Aib*(50%)-Aib-D-αMv-NHMe – S51 
From S48 (73 mg, 0.56 mg) and S6 (72 mg, 0.56 mmol), oxalyl chloride 
(0.10 mL, 1.22 mmol), D-S20 (254 mg, 1.11 mmol) and Et3N (0.16 mL, 
1.11 mmol) according to General Procedure A. Crude S51 was purified by 
flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure compound as a white 
solid (217 mg, 0.64 mmol, 57%). Rf 0.53 (19:1 DCM:MeOH); m.p. 125-127 °C; δH (400 MHz, CDCl3) 7.13 





sep, J = 6.9, CH(CH3)2), 1.51 (3H, s, NHC(CH3)2), 1.47 (7.5H, s, NHC(CH3)2, NHC(CH3), N3C(CH3)2), 1.47 
(1.5H, d, J = 129.7, N3C(13CH3)(CH3)), 1.43 (3H, s, N3(13CH3)(CH3), N3C(CH3)2), 0.86 (3H, d, J = 6.9, 
CH(CH3)2), 0.81 (3H, d, J = 6.9, CH(CH3)2); δC (100 MHz, CDCl3) 173.5 (CONH), 173.0 (CONH), 172.5 
(CONH), 64.0 (N3C(CH3)2), 64.0 (d, J = 36.7, N3C(13CH3)(CH3)), 63.0 (NHC(CH3)), 57.4 (NHC(CH3)2), 35.6 
(CH(CH3)2), 26.3 (NHCH3), 24.2 (N3C(13CH3)(CH3)), 24.0 (NHC(CH3)2), 19.7 (NHC(CH3)) 17.4 (CH(CH3)2), 
16.7 (CH(CH3)2); νmax/cm-1 3358m.br (N-H), 2973m (C-H), 2110s (N3), 1651s (C=O), 1500s (C-N); m/z 
(ESI+) 341.2 and 342.2 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 363.2133 and 364.2147 
[C15H28N6O3Na]+ and [C1413CH28N6O3Na]+ require 363.2121 and 364.2154; [α]D20 = −16.8 (c 1.10; 
CH3OH). 
H-Aib*(50%)-Aib-D-αMv-NHMe – S52 
From S51 (80 mg, 0.24 mmol) according to General Procedure B. S52 
was obtained as a clear film (77 mg, 0.24 mmol, quant.). Rf 0.05 (EtOAc); 
m.p. 203-205 °C; δH (400 MHz, CD3OD) 2.83-2.80 (3H, m, NHCH3), 2.11 
(1H, sep, J = 6.7, CH(CH3)2), 1.57 (3H, s, NHC(CH3)2), 1.55 (3H, s, NHC(CH3)2), 1.51 (3H, s, NHC(CH3)), 
1.41 (4.5H, s, H2NC(CH3)2, H2NC(13CH3)(CH3)), 1.41 (3H, d, J = 129.4, H2NC(13CH3)(CH3)), 1.03-1.01 
(3H, m, CH(CH3)2), 1.01-0.99 (3H, m, CH(CH3)2); δC (100 MHz, CD3OD) 180.5 (CONH), 175.7 (CONH), 
175.7 (CONH), 64.1 (NHC(CH3)), 57.9 (NHC(CH3)2), 55.7 (H2NC(CH3)2), 55.7 (d, J = 36.7, 
H2NC(13CH3)(CH3)), 36.9 (CH(CH3)2), 28.6 (H2NC(13CH3)(CH3), H2NC(CH3)2), 28.4 (H2NC(CH3)(13CH3), 
H2NC(CH3)2), 26.5 (NHCH3), 26.0 (NHC(CH3)2), 24.3 (NHC(CH3)2), 19.6 (NHC(CH3)) 17.7 (CH(CH3)2), 
17.8 (CH(CH3)2); νmax/cm-1 3351m.br (N-H), 2930m (C-H), 1645s (C=O), 1503m (C-N); m/z (ESI+) 315.2 
and 316.3 ([M+H]+, 100%), HRMS (ESI+) found [M+Na]+ 337.2206 and 338.2235 [C15H30N4O3Na]+ and 
[C1413CH30N4O3Na]+ require 337.2216 and 338.2249; [α]D20 = −19.2 (c 1.00; CH3OH). 
N3-Aib-Aib*(50%)-Aib-D-αMv-NHMe – S53 
From S6 (48 mg, 0.37 mmol), oxalyl chloride (0.03 mL, 0.38 mmol), 
S52 (77 mg, 0.24 mmol) and Et3N (0.05 mL, 0.37 mmol) according to 
General Procedure A. Crude S53 was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure compound as a white solid (47 mg, 
0.11 mmol, 45%). Rf 0.38 (19:1 DCM:MeOH); m.p. 131-133 °C; δH (500 MHz, CDCl3) 7.11 (1H, d, J = 4.4, 
NHCH3), 6.88 (1H, s, CONH), 6.76 (1H, s, CONH), 6.39 (1H, s, CONH), 2.77 (3H, d, J = 4.4, NHCH3), 
2.14 (1H, sep, J = 6.2, CH(CH3)2), 1.53 (3H, m, NHC(CH3)2), 1.52 (3H, s, NHC(CH3)2,), 1.51-1.48 (4.5H, m, 
NHC(CH3)2, NHC(13CH3)(CH3)), 1.49 (1.5H, d, J = 129.1, NHC(13CH3)(CH3)), 1.47 (3H, m, NHC(CH3)), 
1.45 (N3C(CH3)2), 1.39 (N3C(CH3)2), 0.94 (3H, d, J = 6.2, CH(CH3)2), 0.92 (3H, d, J = 6.2, CH(CH3)2); δC 





(NHC(CH3)), 57.3 (NHC(CH3)2), 57.2 (NHC(CH3)2) 57.2 (d, J = 36.2, N3C(13CH3)(CH3)), 35.5 (CH(CH3)2), 
27.3 (NHC(CH3)2), 26.5 (NHCH3), 26.1 (N3C(13CH3)major), 24.6 (N3C(CH3)2), 24.3 (N3C(CH3)2), 23.9 
(NHC(13CH3)minor), 23.8 (NHC(CH3)2), 17.9 (NHC(CH3)) 17.6 (CH(CH3)2), 17.2 (CH(CH3)2); νmax/cm-1 
3315m (N-H), 2977m (C-H), 2126m (N3), 1652s (C=O), 1517m (C-N); m/z (ESI+) 448.3 and 449.3 
([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 448.2647 and 449.2686 [C20H35N7O4Na]+ and 
[C1913CH35N7O4Na]+ require 448.2648 and 449.2682; [α]D20 = −23.6 (c 1.00; CH3OH). 
H-Aib-Aib*(50%)-Aib-D-αMv-NHMe – S54 
From S53 (98 mg, 0.23 mmol) according to General Procedure B. 
S54 was obtained as a clear film (81 mg, 0.20 mmol, 87%). Rf 0.01 
(19:1 DCM:MeOH); m.p. 203-205 °C; δH (500 MHz, CDCl3) 8.16 (1H, 
s, CONH), 7.17 (1H, d, J = 4.5, NHCH3), 6.96 (1H, s, CONH), 6.68 (1H, s, CONH), 2.77 (3H, d, J = 4.5, 
NHCH3), 2.15 (1H, sep, J = 6.8, CH(CH3)2), 1.70 (2H, s, br, NH2), 1.48 (3H, s, NHC(CH3)2, 
NHC(13CH3)(CH3)), 1.47 (3H, s, NHC(CH3)2), 1.46 (1.5H, s, NHC(CH3)2), 1.46 (1.5H, d, J = 128.9, 
NHC(13CH3)(CH3)), 1.43 (3H, s, NHC(CH3)2), 1.37 (3H, s, NHC(CH3)), 1.36 (3H, s, H2NC(CH3)2), 1.34 
(3H, s, H2NC(CH3)2), 0.94 (3H, d, J = 6.8, CH(CH3)2), 0.92 (3H, d, J = 6.8, CH(CH3)2); δC (100 MHz, 
CDCl3) 178.5 (CONH), 174.9 (CONH), 174.3 (CONH), 173.2 (CONH), 63.5 (NHC(CH3)), 57.1 
(NHC(CH3)2), 56.7 (NHC(CH3)2), 56.7 (d, J = 36.3, NHC(13CH3)(CH3)), 55.0 (H2NC(CH3)2), 35.6 
(CH(CH3)2), 29.2 (H2NC(CH3)2), 28.9 (NHC(CH3)2, 27.4 (H2NC(CH3)2), 26.5 (NHC(CH3)2), 26.4 (NHCH3), 
26.3 (NHC(13CH3)major), 24.0 (NHC(13CH3)major), 17.9 (NHC(CH3)) 17.7 (CH(CH3)2), 17.3 (CH(CH3)2); 
νmax/cm-1 3317m (N-H), 2967w (C-H), 1646s (C=O), 1525m (C-N); m/z (ESI+) 400.4 and 401.4 ([M+Na]+, 
100%), HRMS (ESI+) found [M+Na]+ 422.2748 and 423.2775 [C19H37N5O4Na]+ and [C1813CH37N5O4Na]+ 
require 422.2743 and 423.2777; [α]D20 = −17.2 (c 1.00; CH3OH). 
N3-Aib*-Aib-Aib*(50%)-Aib-D-αMv-NHMe – S55 
From S48 (22 mg, 0.17 mmol), oxalyl chloride (15 µL, 
0.18 mmol), S54 (44 mg, 0.11 mmol) and Et3N (24 µL, 
0.17 mmol) according to General Procedure A. Crude S55 
was purified by flash column chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure 
compound as a white solid (17 mg, 0.03 mmol, 30%). Rf 0.14 (19:1 DCM:MeOH); m.p. 163-165 °C; 
δH (500 MHz, CDCl3) 7.50 (1H, s, CONH), 7.26 (1H, s, br, CONH), 6.95 (1H, s, CONH), 6.86 (1H, s, 
CONH), 6.15 (1H, s, CONH), 2.79 (3H, d, J = 4.7, NHCH3), 2.13 (1H, sep, J = 6.8, CH(CH3)2), 1.68-1.52 
(5.5H, m, NHC(13CH3)(CH3)major, NHC(13CH3)(CH3)minor, NHC(CH3)2), 1.51-1.44 (17.5H, NHC(CH3)2, 
N3C(13CH3)(CH3)major, N3(13CH3)(CH3)minor, NHC(13CH3)(CH3)major, NHC(13CH3)(CH3)minor, 





N3(13CH3)(CH3)minor), 0.97 (3H, d, J = 6.8, CH(CH3)2), 0.95 (3H, d, J = 6.8, CH(CH3)2); δC (125 MHz, CDCl-
3) 175.1 (CONH), 174.1 (CONH), 174.1 (CONH), 173.3 (CONH), 172.7 (CONH), 64.1 (d, J = 36.7, 
N3C(CH3)2), 63.5 (NHC(CH3)), 57.4 (NHC(CH3)2), 57.2 (NHC(CH3)2), 56.8 (0.5, d, J = 35.3, 
NHC(13CH3)(CH3)), 56.8 (0.5, NHC(CH3)(CH3)), 35.8 (CH(CH3)2), 27.3 (NHC(13CH3)(CH3)minor), 26.5 
(NHCH3), 26.3 (NHC(CH3)2), 25.3 (NHC(CH3)2), 24.6 (N3C(13CH3)(CH3)minor), 24.3 (N3C(13CH3)(CH3)major), 
23.8 (NHC(CH3)2), 23.6 (NHC(CH3)2), 23.5 (NHC(13CH3)(CH3)minor), 18.1 (NHC(CH3)) 17.7 (CH(CH3)2), 
17.2 (CH(CH3)2); νmax/cm-1 3331m.br (N-H), 29761 (C-H), 2112s (N3), 1656s (C=O), 1526m (C-N); m/z 
(ESI+) 512.5 and 513.5 ([M+H]+, 100%), HRMS (ESI+) found [M+Na]+ 534.3212 and 535.3246 
[C2213CH42N8O5Na]+ and [C2113C2H41N8O5Na]+ require 534.3209 and 535.3243; [α]D20 = −19.2 (c 0.50; 
CH3OH). 
H-Aib*-Aib-Aib*(50%)-Aib-D-αMv-NHMe – S56 
From S55 (17 mg, 0.03 mmol) according to General 
Procedure B. S56 was obtained as a clear film (16 mg, 
0.03 mmol, quant.). Rf 0.12 (19:1 DCM:MeOH); m.p. 125-
127 °C; δH (400 MHz, CD3OD) 2.75 (3H, m, NHCH3), 2.15 (1H, sep, J = 6.5, CH(CH3)2), 1.55-1.34 (24H, 
m, NHC(CH3)2, NHC(13CH3)(CH3) NHC(13CH3)(CH3)), 1.48 (3H, s, NHC(CH3)2),  1.48 (1.22-1.17 (3H, m, 
NHC(CH3)), 1.04 (3H, d, J = 6.6, CH(CH3)2), 0.96 (3H, d, J = 6.6, CH(CH3)2); δC (100 MHz, CDCl3) 179.7 
(CONH), 177.3 (CONH), 177.1 (CONH), 177.0 (CONH), 176.2 (CONH), 64.6 (NHC(CH3)), 58.1 
(NHC(CH3)2), 57.5 (0.5, d, J = 35.2, NHC(13CH3)(CH3)), 57.5 (0.5, NHC(CH3)(CH3), 57.5 (NHC(CH3)2), 
55.7 (d, J = 36.4 (NHC(13CH3)(CH3)), 36.9 (CH(CH3)2), 28.5 (H2NC(13CH3)(CH3)minor), 28.3 
(NHC(13CH3)(CH3)major), 27.2 (NHC(CH3)2),  26.5 (NHCH3), 25.8 (NHC(CH3)2), 25.3 (NHC(CH3)2), 26.9 
(H2NC(13CH3)(CH3)minor), 24.1 (NHC(CH3)2), 23.7 (NHC(13CH3)(CH3)minor), 18.3 (NHC(CH3)) 17.7 
(CH(CH3)2), 17.4 (CH(CH3)2); νmax/cm-1 3326w.br (N-H), 2978w (C-H), 1652m (C=O), 1623s (C=O), 
1417m (C-N); m/z (ES-) 485.4 and 486.4 ([M]-, 100%), HRMS (ESI+) found [M+Na]+ 508.3305 and 509.3330 
[C2213CH44N6O5Na]+ and [C2113C2H44N6O5Na]+ require 508.3304 and 509.3338; [α]D20 = −9.3 (c 1.00; 
CH3OH). 
Cbz-L-αMv-Aib3-Aib*-Aib-Aib*(50%)-Aib-D-αMv-NHMe – 6b 
From S30 (105 mg, 0.20 mmol), 
EDC.HCl (57 mg, 0.30 mmol), 
Et3N (42 µL, 0.30 mmol) and S56 
NHMe (98 mg, 0.20 mmol) according to General Procedure F. Crude 6b was purified by automatic 
purification system (99:1 DCM:MeOH increasing to 9:1) to give the pure compound as a white solid 





s, CONH), 7.73 (1H, br, s, CONH), 7.71 (1H, br, s, CONH), 7.68 (1H, br, s, CONH), 7.63 (1H, br, s, 
CONH), 7.51 (1H, br, s, CONH), 7.38 – 7.30 (6H, m, CONH, PhH), 7.12 (1H, br, s, CONH), 6.86 (1H, br, 
s, CONH), 6.11 (1H, br, s, CONH), 5.11 (1H, d, J = 12.5, PhCH2), 5.08 (1H, d, J = 12.5, PhCH2), 2.77 (3H, 
d, J = 4.5, NHCH3), 2.38-2.28 (1H, m, CH(CH3)2), 2.20 (1H, sep, J = 7.0, CH(CH3)2), 1.51 (7.5H, m, 
NHC(CH3)2, NHC(CH3)2(unlabelled) (50%)), 1.51 (1.5H, d, J =129.5, NHC(CH3)(13CH3) NHC(CH3)(13CH3) 
(50%)), 1.49 (9H, m, NHC(CH3)2), 1.48 (3H, d, J =129.5, NHC(CH3)(13CH3), NHC(13CH3)(CH3)  (100%)), 
1.48 (3H, m, NHC(CH3)(13CH3), NHC(13CH3)(CH3)  (100%)), 1.47 (6H, m, NHC(CH3)2), 1.46 (3H, s, 
NHC(CH3)2), 1.43 (3H, s, NHC(CH3)2), 1.42 (3H, s, NHC(CH3)2), 1.42 (3H, s, NHC(CH3)2), 1.41 (3H, s, 
NHC(CH3)), 1.36 (3H, s, NHC(CH3)), 1.00 – 0.94 (12H, m, CH(CH3)2); δC (125 MHz, CDCl3) 176.2 
(CONH), 175.9 (CONH), 175.8 (CONH), 175.7 (CONH), 175.6 (CONH), 175.5 (CONH), 174.7 (CONH), 
174.6 (CONH), 174.2 (CONH), 156.3 (CO2Bn), 136.3, 128.6, 128.4, 127.9 (Ar), 67.0 (PhCH2), 62.9 
(NHC(CH3)), 62.6 (NHC(CH3)), 57.1 (NHC(CH3)2), 56.7 (NHC(CH3)2), 56.7 (NHC(CH3)2), 56.7 
(NHC(CH3)2), 56.6 (0.5, d, J = 37.0, NHC(CH3)(13CH3)), 56.6 (0.5, NHC(CH3)(CH3)), 56.6 (NHC(CH3)2), 
56.5 (d, J=37.5, NHC(CH3)(13CH3)), 34.6 (CH(CH3)2), 34.2 (CH(CH3)2), 27.1 (NHC(CH3)2), 26.9 
(NHC(CH3)2), 26.3 (NHCH3), 26.1 (NHC(CH3)2), 25.3 (NHC(CH3)(13CH3), NHC(CH3)(CH3)), 24.9 
(NHC(CH3)(13CH3)), 22.7 (NHC(CH3)2), 17.8 (CH(CH3)2), 17.6 (CH(CH3)2), 17.6 (CH(CH3)2), 17.4 
(CH(CH3)2); νmax/cm-1 3294m.br (N-H), 2984m (C-H), 1655s (C=O), 1533m (C-N); m/z (ESI+) 1010.6 and 
1011.6 ([M+Na]+, 100%), HRMS (ESI+) found [M+Na]+ 1010.6085 and 1011.6114 [C4813CH82N10O11Na] and 
[C4713C2H82N10O11Na] require 1010.6090 and 1011.6124; [α]D20 = −0.7 (c 1.00; CH3OH). 
N3-Aib2-D-αMv-NHMe – S57 
From S6 (262 mg, 2.03 mmol), oxalyl chloride (0.55 mL, 2.03 mmol), D-S20 
(310 mg, 1.35 mmol) and Et3N (0.29 mL, 2.03 mmol) according to General 
Procedure A. Crude S57 was purified by flash column chromatography (99:1 
DCM:MeOH increasing to 19:1) to give the pure compound as a white solid (168 mg, 0.49 mmol, 36%). Rf 
0.53 (19:1 DCM:MeOH); m.p. 125-127 °C; δH (500 MHz, CDCl3) 7.07 (1H, d, J = 4.5, NHCH3), 6.95 (1H, 
s, CONH), 6.21 (1H, s, CONH), 2.72 (3H, d, J = 4.5, NHCH3), 2.12 (1H, sep, J = 6.9, CH(CH3)2), 1.50 (3H, 
s, NHC(CH3)2), 1.47 (6H, s, NHC(CH3)2, NHC(CH3)), 1.47 (3H, s, N3C(CH3)2), 1.43 (3H, s, N3C(CH3)2), 
0.86 (3H, d, J = 6.9, CH(CH3)2), 0.82 (3H, d, J = 6.9, CH(CH3)2); δC (125 MHz, CDCl3) 173.7 (CONH), 
173.1 (CONH), 172.6 (CONH), 64.1 (N3C(CH3)2), 63.3 (NHC(CH3)), 57.5 (NHC(CH3)2), 35.6 (CH(CH3)2), 
26.4 (NHCH3), 25.8 (N3C(CH3)2), 24.3 (NHC(CH3)2), 19.7 (NHC(CH3)) 17.4 (CH(CH3)2), 16.8 (CH(CH3)2); 
νmax/cm-1 3353m.br (N-H), 2978m (C-H), 2111s (N3), 1652s (C=O), 1502s (C-N); m/z (ESI+) 341.2 
([M+H]+, 100%), HRMS (ESI+) found [M+H]+ 341.2317 [C15H29N6O3]+ requires 341.2301; [α]D20 = −16.8 





H-Aib2-D-αMv-NHMe – S58 
From S57 (168 mg, 0.49 mmol) according to General Procedure B. S58 
was obtained as a clear film (116 mg, 0.37 mmol, 76%). Rf 0.05 (EtOAc); 
m.p. 203-205 °C; δH (400 MHz, CDCl3) 8.22 (1H, s, CONH), 7.36 (1H, d, J = 
4.6, CONH), 6.29 (1H, s, CONH), 2.76 (3H, d, J = 4.6, NHCH3), 2.13 (1H, sep, J = 6.9, CH(CH3)2), 1.78 
(2H, s, br, NH2), 1.54 (3H, s, NHC(CH3)2), 1.49 (3H, s, NHC(CH3)2), 1.46 (3H, s, NHC(CH3)), 1.34 (6H, s, 
H2NC(CH3)2), 0.90 (3H, d, J = 6.9, CH(CH3)2), 0.85 (3H, d, J = 6.9, CH(CH3)2); δC (100 MHz, CDCl3) 178.8 
(CONH), 173.9 (CONH), 173.3 (CONH), 63.2 (NHC(CH3)), 57.0 (NHC(CH3)2), 55.0 (H2NC(CH3)2), 35.8 
(CH(CH3)2), 29.1 (H2NC(CH3)2), 28.9 (H2NC(CH3)2), 26.5 (NHCH3), 26.2 (NHC(CH3)2), 24.3 (NHC(CH3)2), 
20.0 (NHC(CH3)) 17.6 (CH(CH3)2), 16.8 (CH(CH3)2); νmax/cm-1 3329m.br (N-H), 2967m (C-H), 1649s 
(C=O), 1503m (C-N); m/z (ESI+) 315.2 ([M+H]+, 100%), HRMS (ESI+) found [M+Na]+ 337.2221 [C15H-
30N4O3Na]+ requires 337.2216; [α]D20 = −16.4 (c 1.00; CH3OH). 
N3-Aib*-Aib2-D-αMv-NHMe – S59 
From S48 (48 mg, 0.37 mmol), oxalyl chloride (34 µL, 0.41 mmol), S58 
(92 mg, 0.29 mmol) and Et3N (57 µL, 0.41 mmol) according to General 
Procedure A. Crude S59 was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure compound as a white solid (30 mg, 
0.07 mmol, 24%). Rf 0.38 (19:1 DCM:MeOH); m.p. 130-132 °C; δH (500 MHz, CDCl3) 7.14 (1H, d, J = 4.6, 
NHCH3), 6.91 (1H, s, CONH), 6.78 (1H, s, CONH), 6.41 (1H, s, CONH), 2.77 (3H, d, J = 4.6, NHCH3), 
2.13 (1H, sep, J = 6.8, CH(CH3)2), 1.54-1.47 (12H, m, NHC(CH3)2), 1.46 (3H, s, NHC(CH3)2,), 1.44 (3H, s, 
NHC(CH3)), 1.41-1.33 (6H, m, N3C(CH3)), 0.93 (3H, d, J = 6.8, CH(CH3)2), 0.92 (3H, d, J = 6.8, CH(CH3)2); 
δC (125 MHz, CDCl3) 174.7 (CONH), 173.6 (CONH), 172.9 (CONH), 172.8 (CONH), 64.2 (d, J = 37.1, 
N3C(CH3)2), 63.5 (NHC(CH3)), 57.3 (NHC(CH3)2), 57.2 (NHC(CH3)2), 35.5 (CH(CH3)2), 27.3 (NHC(CH3)2), 
26.5 (NHCH3), 26.1 (NHC(CH3)2), 24.6 (N3C(13CH3)minor), 24.3 (N3C(13CH3)major), 23.9 (NHC(CH3)2), 23.7 
(NHC(CH3)2), 17.9 (NHC(CH3)) 17.6 (CH(CH3)2), 17.2 (CH(CH3)2); νmax/cm-1 3336m.br (N-H), 2977m 
(C-H), 2113m (N3), 1659s (C=O), 1514s (C-N); m/z (ESI+) 427.3 ([M+H]+, 100%), HRMS (ESI+) found 
[M+Na]+ 449.2676 [C1813CH35N7O4Na]+ requires 449.2682; [α]D20 = −12.4 (c 1.10; CH3OH). 
 
 





From S59 (25 mg, 0.06 mmol) according to General Procedure B. 
S60 was obtained as a clear film (23 mg, 0.06 mmol, quant.). Rf 0.00 
(19:1 DCM:MeOH); m.p. 203-205 °C; δH (400 MHz, CD3OD) 2.65 
(3H, s, NHCH3), 2.09 (1H, sep, J = 6.8, CH(CH3)2), 1.36 (3H, s, NHC(CH3)2), 1.34 (3H, s, NHC(CH3)2), 
1.31 (3H, s, NHC(CH3)2), 1.30 (3H, s, NHC(CH3)2), 1.26 (3H, s, NHC(CH3)), 1.26-1.21 (3H, m, 
H2NC(CH3)2), 1.11-1.06 (3H, m, H2NC(CH3)2), 0.92 (3H, d, J = 6.8, CH(CH3)2), 0.83 (3H, d, J = 6.8, 
CH(CH3)2); δC (100 MHz, CD3OD) 179.6 (CONH), 177.4 (CONH), 177.0 (CONH), 176.6 (CONH), 64.5 
(NHC(CH3)), 57.9 (NHC(CH3)2), 57.3 (NHC(CH3)2), 55.8 (d, J = 36.5, H2NC(CH3)2), 36.6 (CH(CH3)2), 28.7 
(H2NC(13CH3))major, 28.4 (NHC(CH3)2, 28.1 (H2NC(13CH3))minor, 27.2 (NHC(CH3)2), 26.4 (NHCH3), 25.5 
(NHC(CH3)2), 25.0 (NHC(CH3)2), 18.4 (NHC(CH3)) 17.8 (CH(CH3)2), 16.8 (CH(CH3)2); νmax/cm-1 3339w.br 
(N-H), 2973w (C-H), 1649s (C=O), 1413m (C-N); m/z (ESI+) 423.8 ([M+Na]+, 100%), 401.3 ([M+H]+, 60%), 
HRMS (ESI+) found [M+Na]+ 423.2756 [C1813CH37N5O4Na]+ requires 423.2777; [α]D20 = −2.4 (c 0.50; 
CH3OH). 
Cbz-L-αMv-Aib4-Aib*-Aib2-D-αMv-NHMe – 6c 
From S37 (38 mg, 0.06 mmol), 
EDC.HCl (18 mg, 0.09 mmol), 
DIPEA (16 µL, 0.09 mmol) and S60 
(23 mg, 0.06 mmol) according to General Procedure F. Crude 6c was purified by flash column 
chromatography (99:1 DCM:MeOH increasing to 19:1) to give the pure compound as a clear solid (10 mg, 
0.01 mmol, 17%). Rf 0.17 (19:1 DCM:MeOH); m.p. >250 °C; δH (500 MHz, CDCl3) 7.72-7.70 (2H, m, 
CONH) 7.68 (1H, s, CONH), 7.63 (1H, s, CONH), 7.60 (1H, s, CONH), 7.48 (1H, s, CONH), 7.39-7.32 
(6H, m, PhH, CONH), 7.06 (1H, s, CONH), 6.54 (1H, s, CONH), 5.59 (1H, s, CONH), 5.03 (2H, ABq, ΔδAB 
= 0.03, JAB = 12.3, PhCH2), 2.79 (3H, d, J = 4.6, NHCH3), 2.34 (1H, m, CH(CH3)2), 2.13 (1H, m. CH(CH3)2), 
1.52-1.50 (9H, m, NHC(CH3)2), 1.49 (6H, s, NHC(CH3)2), 1.47 (12H, s, NHC(CH3)2), 1.46 (6H, s, 
NHC(CH3)2), 1.44 (3H, s, NHC(CH3)2), 1.43 (3H, s, NHC(CH3)2), 1.41 (6H, s, NHC(CH3)2, NHC(CH3)), 
1.33 (3H, s, NH(CH3)), 0.99 (3H, d, J = 7.2, CH(CH3)2), 0.97 (3H, d, J = 7.2, CH(CH3)2), 0.96 (3H, d, J = 6.4, 
CH(CH3)2), 0.95 (3H, d, J = 6.4, CH(CH3)2); δC (125 MHz, CDCl3); 176.2 (CONH), 175.8 (CONH), 	175.7 
(CONH), 	 175.5 (CONH), 	 175.4 (CONH), 	 174.6 (CONH), 	 174.4 (CONH), 	 173.6 (CONH), 	 156.3 
(CO2Bn), 136.0, 128.9, 128.8, 128.2 (Ar), 67.6 (PhCH2), 63.0 (NHC(CH3)), 62.8 (NHC(CH3)), 57.2 
(NHC(CH3)2),	 56.9 (NHC(CH3)2), 56.9 (NHC(CH3)2), 56.7 (NHC(CH3)2), 56.7 (NHC(CH3)2), 56.6 
(NHC(CH3)2), 56.6 (NHC(CH3)2), 30.5 (CH(CH3)2), 29.9 (CH(CH3)2), 26.9 (NHC(CH3)2), 26.5 (NHCH3), 
26.4 (NHC(CH3)2), 25.6-24.6 (NHC(CH3)2), NHC(13CH3)), 18.5 (NHC(CH3)), 18.0 (NHC(CH3)), 18.0 





(C-H), 1655s (C=O), 1535m (C-N); m/z (ESI+) 1010.7 ([M+Na]+, 100%), HRMS (ESI-) found [M-H]- 
































































































































































































































































































3. Computational methods 
REMD Simulations. Aib, (R)- and (S)-αMeVal amino acids and the Cbz protecting group were designed 
using MOE11, the formers capped with an acetyl (Ac) and a NHMe group at the N- and C-termini, 
respectively, while the latter capped with the only NHMe group. They were then submitted to a “Low 
Mode” conformational search by setting MMFF94x as force field, Born solvation model, iteration limit = 
40000, MM iteration limit = 2500, and rejection limit = 500. For each molecule, the two conformations 
showing the lowest energy and, in the case of the three amino acids, with the φ and ψ dihedrals 
corresponding to the right- and left-handed helical ones (φ = ±60° and ψ = ±45°) were chosen for partial 
charges derivation performed by the R.E.D.IV software12. For this step, the selected geometries were 
optimized at the HF/6-31G(d) theory level and the RESP-A1 charges were derived using two different 
spatial orientations, in order to have an orientation- and conformation-independent charge derivation. 
Moreover, the amino acids backbone nitrogen, hydrogen, carbonyl carbon and oxygen charges were fixed 
at the values reported in the AMBER ff99SBildn-φ force field13 for standard amino acids (e.g. -0.4157, 
0.2719, 0.5973 and -0.5679, respectively). 
Cbz-(S)-αMeVal2-Aib5-(S)-αMeVal2-NHMe (1a) and Cbz-(S)-αMeVal2-Aib5-(R)-αMeVal2-NHMe (1b) 
peptides were built by imposing an extended conformation (φ = ψ = ω = 180°). REMD simulations in 
implicit solvent of the two peptides were performed using the AMBER ff99SBildn-φ force field coupled with 
the implicit solvent model GB-Neck2 (igb = 8),14 combination that proved to give the best results in 
predicting peptides secondary structures.15 16 replica, spanning temperatures between 260.00 K and 690.08 
K with a 0.5 probability exchange, were run for 100 ns each, for a total of 1.6 µs of simulation for each 
peptide, using the pmemd module of the Amber14 package.16 The trajectories at 297.31 K were extracted, 
unless stated otherwise, and analyzed on the 50-100 ns time interval.  
For the REMD simulations in explicit methanol, the Cbz-(S)-αMeVal2-Aib5-(R)-αMeVal2-NHMe peptide in 
the extended conformation was solvated with an octahedral box of 1290 MeOH molecules (closeness = 8.0 
Å) and preliminary submitted to minimization and equilibrations cycles. Initially 5000 cycles of hydrogens 
minimization (1000 cycles of steepest descent and 4000 cycles of conjugated gradient), followed by 5000 
cycles of solvent minimization (2000 cycles of steepest descent and 3000 cycles of conjugated gradient) 
were carried out. Then, the solvent box was equilibrated at 300 K by 1ns of NVT equilibration and 1ns of 
NPT equilibration using the Langevin thermostat with a frequency collision on 2.0. This step was followed 
by 5000 cycles (2500 of steepest descent and 2500 of conjugated gradient) of solvent and sidechains 
minimization and by 5000 cycles (2500 of steepest descent and 2500 of conjugated gradient) of total 
minimization. The last step consisted in 100 ps of NVT and 100 ps of NPT equilibration of the whole 





force field and by performing 40 replica of 120 ns each (4.8 µs totally) between 290.00 K and 511.61 with 
an exchange probability of 0.20. The trajectory at 303.60 K was extracted, the solvent was stripped out and 
the simulation convergence was checked every 10 ns by assuring that the conformations obtained during 
the 10 ns time intervals were similar on the base of the Root Mean Square Deviation (RMSD). 
Cluster analyses were performed with Amber1416 cpptraj using the average-linkage algorithm and the 
pairwise mass-weighted RMSD on the Cα of residues 7-11, in order to clearly identify where the inversion 
of the screw helical sense occurs. For the simulations conducted in implicit solvent the 50-100 ns time 
interval was analyzed by sampling one every four frames and by requesting 5 clusters on the basis of 
pseudo-F statistics and SSR/SST ratio.17 As regards the REMD in explicit solvent, since convergence was 
reached after 50 ns, the last 60 ns were submitted to cluster analysis, one every four frames was sampled 
and 15 clusters were requested. 
H-bond occupancies during the simulations were computed with VMD 1.9.118 over the whole trajectories 
for the simulations in implicit solvent and on the last 60 ns for that in explicit methanol, with a donor-
acceptor distance limit of 4.0 Å and an angle cutoff of 60°. This very low angle acceptance threshold was 
chosen in order to be able to identify also the presence of γ-turns, since it has been showed that the 
hydrogen bond in γ-turns is highly bent19 and the N-H-O angle can reach values of 110-130°. Only H-bonds 
with an occupancy greater than 5% were considered. The H-bond analysis between peptide 2 and methanol 
molecules was performed with Amber14 cpptraj, using successively the backbone carbonyl oxygen atoms as 
acceptor atoms and setting methanol molecules as solvent donor, then the methanol residues were 
considered as solvent acceptor and the backbone amidic hydrogens were considered as donor atoms. In 
this case the distance cutoff was set to 4.0 Å and the minimum angle accepted was fixed at 150°, as for 
standard H-bonds. 
Potential of Mean Force (PMF) as a function of φ and ψ dihedrals were computed with Amber software 
coupled with the Weighted Histogram Analysis Method (WHAM)20 over the whole implicit solvent 
trajectories and over the last 60 ns for the explicit methanol simulation by setting a histogram limit of 
±180°, 100 bins and a tolerance of 0.01. Temperatures between 260.00 K and 317.73 K were considered. A 










Table S1. H-bond analyses of REMD trajectories of peptides 1a and 1b (Donor, N-H; Acceptor, C=O). 
peptide 1a    peptide 1b   
donor acceptor occupancy  Donor acceptor occupancy 
Aib4 (S)-αMeVal1 90.24%  Aib4 (S)-αMeVal1 88.43% 
Aib5 (S)-αMeVal2 93.05%  Aib5 (S)-αMeVal2 86.74% 
Aib6 Aib3 92.92%  Aib6 Aib3 86.11% 
Aib7 Aib4 92.74%  Aib7 Aib4 86.95% 
Aib7 Aib5 6.52%  Aib7 Aib5 8.42% 
(S)-αMeVal8 Aib5 73.44%  (R)-αMeVal8 Aib5 56.07% 
(S)-αMeVal8 Aib6 7.46%  (R)-αMeVal8 Aib6 10.50% 
(S)-αMeVal9 Aib6 77.69%  (R)-αMeVal9 Aib6 59.00% 
(S)-αMeVal9 Aib7 6.91%  (R)-αMeVal9 Aib7 8.40% 
Table S2. H-bond analysis of explicit solvent REMD trajectory of peptide 1b. 
donor acceptor occ%  Donor Acceptor Frac%§ Donor Acceptor Frac%§ 
Aib4 (S)-αMeVal1 82.83  (S)-αMeVal1 MeOH 70.4  MeOH (R)-αMeVal9 71.55 
Aib3 (S)-αMeVal1 7.38  (S)-αMeVal2 MeOH 41.5  MeOH (R)-αMeVal8 61.03 
Aib5 (S)-αMeVal2 81.43  Aib6 MeOH 11.9  MeOH Aib7 41.68 
Aib4 (S)-αMeVal2 5.9  Aib5 MeOH 11.4  MeOH Aib3 34.52 
Aib6 Aib3 79.53  Aib7 MeOH 9.85  MeOH Aib4 31.52 
Aib5 Aib3 6.06  Aib4 MeOH 7.09  MeOH Aib5 29.84 
Aib7 Aib4 81.81  (R)-αMeVal8 MeOH 3.79  MeOH (S)-αMeVal2 26.68 
Aib6 Aib4 5.55  Aib3 MeOH 3.6  MeOH (S)-αMeVal1 24.73 
(R)-
αMeVal8 
Aib5 73.43  (R)-αMeVal9 MeOH 0.83  MeOH Aib6 22.45 
Aib7 Aib5 8.93         
(R)-
αMeVal9 
Aib6 75.51         
(R)-
αMeVal8 
Aib6 14.83         
(R)-
αMeVal9 
Aib7 11.41         
§ The frac% doesn’t represent a real occupancy, since for any given frame more than one solvent molecule 





Table S3. Variation helical excess with position in the chain for the achiral Aib5 domain of 1a calculated 
from the Boltzmann distributions resulting from PMF profiles in implicit solvent. 
Aib res Erel (kcal/mol) B-factora h.e.% 
 M P M P  
1 1.66 0.00 0.06 1.00 88.38 
2 1.32 0.00 0.11 1.00 80.18 
3 1.30 0.00 0.11 1.00 80.18 
4 1.08 0.00 0.16 1.00 72.41 
5 1.51 0.00 0.08 1.00 85.19 
aCalculated as 𝑒𝑥𝑝 !!!"#!"  with R being the gas constant and T the temperature (300K). 
Table S4. Variation helical excess with position in the chain for the achiral Aib5 domain of 1b calculated 
from the Boltzmann distributions resulting from PMF profiles in implicit solvent. 
Aib res Erel (kcal/mol)a B-factorb h.e.% 
 M P M P  
1 1.53 0.00 0.08 1.00 85.19 
2 0.98 0.00 0.19 1.00 68.07 
3 0.62 0.00 0.35 1.00 48.15 
4 0.39 0.00 0.52 1.00 31.58 
5 -0.57 0.00 2.60 1.00 -44.44 
aCalculated as 𝑒𝑥𝑝 !!!"#!"  with R being the gas constant and T the temperature (300K). 
Table S5. Variation of helical excess with position in the chain for the achiral Aib5 domain of 1b calculated 
from the Boltzmann distributions resulting from PMF profiles in explicit methanol. 
Aib res Erel (kcal/mol)a B-factorb h.e.% 
 M P M P  
1 0.75 0.00 0.28 1.00 56.25 
2 0.32 0.00 0.58 1.00 26.58 
3 -0.10 0.00 1.18 1.00 -8.23 
4 -0.43 0.00 2.06 1.00 -34.64 
5 -0.77 0.00 3.64 1.00 -56.90 






4. Raman spectroscopy 
Experimental procedure 
Raman spectra were recorded on a ChiralRaman spectrometer (BioTools Inc., USA). Solutions of 
compounds 1a, 1b, 5a, 5b and N3Aib2OtBu,5 were prepared in CHCl3 (100 µL, 60 mg/mL). All 
measurements were performed at 25 °C. Spectral deconvolution was performed using Origin Pro9. 
Raman spectra of 1a and 1b 
Foldamers 1a and 1b both present one peak, centred at about 1664 cm-1, in the amide I region after 
deconvolution. The position of this peak is consistent with foldamer in a 310 helical conformation. 
 
Figure S1: Amide I region of foldamers a) 1a and b) 1b in CHCl3. The black trace shows the experimental 
data, the green trace (obscured) shows the peak deconvolution and the red trace shows the calculated 
cumulative peak. 
Raman spectra of 5a, 5b and N3Aib2OtBu 
The deconvolution of the amide I region for the peptides 5a and 5b showed the peptides are principally 
310-helical. Deconvolution shows that 95% of the population is given by the peak at 1661 cm-1 and 5% by 






Figure S2: Amide I region of foldamers a) 5a and b) 5b in CHCl3. The black trace shows the experimental 
data, the green trace shows the peak deconvolution and the red trace shows the calculated cumulative 
peak. 
The Raman spectrum of the dimer N3Aib2OtBu, which is too short to fold into a helix, shows only a single 
amide 1 band at 1681 cm–1 after deconvolution, suggesting that the additional peak at 1682 cm-1 in the 
Raman spectra of 5a and 5b arises from unfolded conformations. 
 
Figure S3: Amide I region of dimer N3Aib2OtBu in CHCl3. The black trace shows the experimental data, 
the green trace (obscured) shows the peak deconvolution and the red trace shows the calculated 
cumulative peak. 
 
5. X-ray crystallography 
X-ray crystal structure data for 1a and 1b have been deposited at the CCDC with the deposition numbers 
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